BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med. 2000;192:1197-1204. [PMID: 11034610 DOI: 10.1084/jem.192.8.1197] [Cited by in Crossref: 767] [Cited by in F6Publishing: 719] [Article Influence: 34.9] [Reference Citation Analysis]
Number Citing Articles
1 Regidor PA, Santos FG, Rizo JM, Egea FM. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19. Med Hypotheses 2020;145:110340. [PMID: 33069094 DOI: 10.1016/j.mehy.2020.110340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101. [PMID: 24899309 DOI: 10.1038/nature13479] [Cited by in Crossref: 1482] [Cited by in F6Publishing: 1393] [Article Influence: 185.3] [Reference Citation Analysis]
3 Wu H, Xu L, Ballantyne CM. Dietary and Pharmacological Fatty Acids and Cardiovascular Health. J Clin Endocrinol Metab 2020;105:dgz174. [PMID: 31678992 DOI: 10.1210/clinem/dgz174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Aursnes M, Tungen JE, Colas RA, Vlasakov I, Dalli J, Serhan CN, Hansen TV. Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages. J Nat Prod 2015;78:2924-31. [PMID: 26580578 DOI: 10.1021/acs.jnatprod.5b00574] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
5 Rius B, López-Vicario C, González-Périz A, Morán-Salvador E, García-Alonso V, Clária J, Titos E. Resolution of inflammation in obesity-induced liver disease. Front Immunol 2012;3:257. [PMID: 22934096 DOI: 10.3389/fimmu.2012.00257] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
6 Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB. The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne) 2020;11:591819. [PMID: 33329396 DOI: 10.3389/fendo.2020.591819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Xia H, Wang J, Sun S, Wang F, Yang Y, Chen L, Sun Z, Yao S. Resolvin D1 Alleviates Ventilator-Induced Lung Injury in Mice by Activating PPARγ/NF-κB Signaling Pathway. Biomed Res Int 2019;2019:6254587. [PMID: 31275979 DOI: 10.1155/2019/6254587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol. 2009;158:413-428. [PMID: 19422375 DOI: 10.1111/j.1476-5381.2009.00189.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 7.4] [Reference Citation Analysis]
9 Polus A, Zapala B, Razny U, Gielicz A, Kiec-Wilk B, Malczewska-Malec M, Sanak M, Childs CE, Calder PC, Dembinska-Kiec A. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim Biophys Acta 2016;1861:1746-55. [PMID: 27531277 DOI: 10.1016/j.bbalip.2016.08.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
10 Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest 2018;128:2713-23. [PMID: 30108191 DOI: 10.1172/JCI97950] [Cited by in Crossref: 92] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
11 Rius B, Titos E, Morán‐salvador E, López‐vicario C, García‐alonso V, González‐périz A, Arroyo V, Claria J. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis. FASEB j 2013;28:836-48. [DOI: 10.1096/fj.13-235614] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
12 Chiu CY, Gomolka B, Dierkes C, Huang NR, Schroeder M, Purschke M, Manstein D, Dangi B, Weylandt KH. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm Res. 2012;61:967-976. [PMID: 22618200 DOI: 10.1007/s00011-012-0489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
13 Zheng DJ, Abou Taka M, Heit B. Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease. Pathogens 2021;10:134. [PMID: 33572846 DOI: 10.3390/pathogens10020134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Prescott SM, Stenson WF. Fish oil fix. Nat Med 2005;11:596-8. [DOI: 10.1038/nm0605-596] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
15 Chee B, Park B, Fitzsimmons T, Coates AM, Bartold PM. Omega-3 fatty acids as an adjunct for periodontal therapy-a review. Clin Oral Investig 2016;20:879-94. [PMID: 26885664 DOI: 10.1007/s00784-016-1750-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
16 Louis NA, Hamilton KE, Colgan SP. Lipid mediator networks and leukocyte transmigration. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;73:197-202. [DOI: 10.1016/j.plefa.2005.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
17 Yu H, Su X, Lei T, Zhang C, Zhang M, Wang Y, Zhu L, Liu J. Effect of Omega-3 Fatty Acids on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Chron Obstruct Pulmon Dis 2021;16:2677-86. [PMID: 34588776 DOI: 10.2147/COPD.S331154] [Reference Citation Analysis]
18 Vartak T, Godson C, Brennan E. Therapeutic potential of pro-resolving mediators in diabetic kidney disease. Adv Drug Deliv Rev 2021;178:113965. [PMID: 34508793 DOI: 10.1016/j.addr.2021.113965] [Reference Citation Analysis]
19 Bazan NG, Calandria JM, Serhan CN. Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J Lipid Res 2010;51:2018-31. [PMID: 20382842 DOI: 10.1194/jlr.R001131] [Cited by in Crossref: 93] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
20 Das UN. Clinical Laboratory Tools to Diagnose Inflammation. Advances in Clinical Chemistry Volume 41. Elsevier; 2006. pp. 189-229. [DOI: 10.1016/s0065-2423(05)41006-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
21 Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends in Endocrinology & Metabolism 2015;26:315-21. [DOI: 10.1016/j.tem.2015.03.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 14.9] [Reference Citation Analysis]
22 Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol. 2004;5:388-392. [PMID: 15034576 DOI: 10.1038/ni1056] [Cited by in Crossref: 243] [Cited by in F6Publishing: 230] [Article Influence: 13.5] [Reference Citation Analysis]
23 Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res. 2012;51:232-237. [PMID: 22542696 DOI: 10.1016/j.plipres.2012.02.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 10.0] [Reference Citation Analysis]
24 Stapleton RD, Martin JM, Mayer K. Fish oil in critical illness: mechanisms and clinical applications. Crit Care Clin 2010;26:501-14, ix. [PMID: 20643303 DOI: 10.1016/j.ccc.2010.04.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
25 Liu G, Wan N, Liu Q, Chen Y, Cui H, Wang Y, Ren J, Shen X, Lu W, Yu Y, Shen Y, Wang J. Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling. Hypertension 2021;78:1914-26. [PMID: 34689593 DOI: 10.1161/HYPERTENSIONAHA.121.17809] [Reference Citation Analysis]
26 Nadtochiy SM, Redman EK. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition 2011;27:733-44. [PMID: 21454053 DOI: 10.1016/j.nut.2010.12.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
27 Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007;282:9323-34. [PMID: 17244615 DOI: 10.1074/jbc.M609212200] [Cited by in Crossref: 345] [Cited by in F6Publishing: 210] [Article Influence: 23.0] [Reference Citation Analysis]
28 Rueda F, Domingo J, Mach N. Efectos de los ácidos grasos omega 3 y otros suplementos alimenticios en procesos patológicos relacionados con la tercera edad. Revista Española de Nutrición Humana y Dietética 2011;15:20-9. [DOI: 10.1016/s2173-1292(11)70004-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Serhan CN, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins & Other Lipid Mediators 2004;73:155-72. [DOI: 10.1016/j.prostaglandins.2004.03.005] [Cited by in Crossref: 209] [Cited by in F6Publishing: 183] [Article Influence: 11.6] [Reference Citation Analysis]
30 Van Biervliet S, Van Biervliet J, Robberecht E, Christophe A. Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials. Journal of Cystic Fibrosis 2005;4:27-34. [DOI: 10.1016/j.jcf.2004.11.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
31 Kwong RY, Heydari B, Ge Y, Abdullah S, Fujikura K, Kaneko K, Harris WS, Jerosch-Herold M, Antman EM, Seidman JG, Pfeffer MA. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial. PLoS One 2019;14:e0222061. [PMID: 31532795 DOI: 10.1371/journal.pone.0222061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 von Hegedus JH, Kahnt AS, Ebert R, Heijink M, Toes REM, Giera M, Ioan-Facsinay A. Toll-like receptor signaling induces a temporal switch towards a resolving lipid profile in monocyte-derived macrophages. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158740. [PMID: 32447052 DOI: 10.1016/j.bbalip.2020.158740] [Reference Citation Analysis]
33 Das UN, Madhavi N. Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis 2011;10:159. [PMID: 21917129 DOI: 10.1186/1476-511X-10-159] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
34 Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of anti-ageing? Semin Immunol 2018;40:36-48. [PMID: 30293857 DOI: 10.1016/j.smim.2018.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
35 Fiala M, Terrando N, Dalli J. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment. J Alzheimers Dis 2015;48:293-301. [PMID: 26401996 DOI: 10.3233/JAD-150367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
36 Corminboeuf O, Leroy X. FPR2/ALXR agonists and the resolution of inflammation. J Med Chem 2015;58:537-59. [PMID: 25365541 DOI: 10.1021/jm501051x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
37 Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 2018;100:1292-311. [PMID: 30571942 DOI: 10.1016/j.neuron.2018.11.009] [Cited by in Crossref: 172] [Cited by in F6Publishing: 168] [Article Influence: 57.3] [Reference Citation Analysis]
38 Kaput J, Noble J, Hatipoglu B, Kohrs K, Dawson K, Bartholomew A. Application of nutrigenomic concepts to Type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2007;17:89-103. [PMID: 17276047 DOI: 10.1016/j.numecd.2006.11.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
39 Siddiqui RA, Harvey KA, Zaloga GP. Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. The Journal of Nutritional Biochemistry 2008;19:417-37. [DOI: 10.1016/j.jnutbio.2007.07.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
40 Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27:200-215. [PMID: 25857211 DOI: 10.1016/j.smim.2015.03.004] [Cited by in Crossref: 310] [Cited by in F6Publishing: 283] [Article Influence: 44.3] [Reference Citation Analysis]
41 Regidor PA, Mueller A, Sailer M, Gonzalez Santos F, Rizo JM, Egea FM. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Int J Mol Sci 2020;22:E384. [PMID: 33396555 DOI: 10.3390/ijms22010384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Neto J, Jantsch J, de Oliveira S, Braga MF, Castro LFDS, Diniz BF, Moreira JCF, Giovenardi M, Porawski M, Guedes RP. DHA/EPA supplementation decreases anxiety-like behaviour, but it does not ameliorate metabolic profile in obese male rats. Br J Nutr 2021;:1-11. [PMID: 34605386 DOI: 10.1017/S0007114521003998] [Reference Citation Analysis]
43 Gao L, Faibish D, Fredman G, Herrera BS, Chiang N, Serhan CN, Van Dyke TE, Gyurko R. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol 2013;190:689-94. [PMID: 23241890 DOI: 10.4049/jimmunol.1103688] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
44 Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, Serhan CN, Bonventre JV. Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury. J Immunol 2006;177:5902-11. [DOI: 10.4049/jimmunol.177.9.5902] [Cited by in Crossref: 237] [Cited by in F6Publishing: 229] [Article Influence: 14.8] [Reference Citation Analysis]
45 Guichardant M, Calzada C, Bernoud-Hubac N, Lagarde M, Véricel E. Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis. Biochim Biophys Acta 2015;1851:485-95. [PMID: 25263947 DOI: 10.1016/j.bbalip.2014.09.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
46 Reinertsen AF, Primdahl KG, Shay AE, Serhan CN, Hansen TV, Aursnes M. Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4. J Org Chem 2021;86:3535-45. [PMID: 33534565 DOI: 10.1021/acs.joc.0c02913] [Reference Citation Analysis]
47 Gottschall H, Schmöcker C, Hartmann D, Rohwer N, Rund K, Kutzner L, Nolte F, Ostermann AI, Schebb NH, Weylandt KH. Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue. J Lipid Res 2018;59:864-71. [PMID: 29444936 DOI: 10.1194/jlr.M078725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Small M, Serhan CN, Libreros S, Nshimiyimana R. E-series Resolvin Metabolome, Biosynthesis and Critical Role of Stereochemistry of Specialized Pro-Resolving Mediators (SPMs) in Inflammation-Resolution: Preparing SPMs for Long COVID-19, Human Clinical Trials, and Targeted Precision Nutrition. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101597] [Reference Citation Analysis]
49 Qiu W, Guo K, Yi L, Gong Y, Huang L, Zhong W. Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection. Exp Ther Med 2014;7:1481-5. [PMID: 24926330 DOI: 10.3892/etm.2014.1641] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
50 Yang M, Bair JA, Hodges RR, Serhan CN, Dartt DA. Resolvin E1 Reduces Leukotriene B4-Induced Intracellular Calcium Increase and Mucin Secretion in Rat Conjunctival Goblet Cells. Am J Pathol 2020;190:1823-32. [PMID: 32561135 DOI: 10.1016/j.ajpath.2020.06.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Bennett M, Gilroy DW. Lipid Mediators in Inflammation. Microbiol Spectr 2016;4. [PMID: 27837747 DOI: 10.1128/microbiolspec.MCHD-0035-2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
52 Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010;107:1170-84. [PMID: 21071715 DOI: 10.1161/CIRCRESAHA.110.223883] [Cited by in Crossref: 266] [Cited by in F6Publishing: 133] [Article Influence: 22.2] [Reference Citation Analysis]
53 Andreassen OA, Desikan RS, Wang Y, Thompson WK, Schork AJ, Zuber V, Doncheva NT, Ellinghaus E, Albrecht M, Mattingsdal M, Franke A, Lie BA, Mills IG, Aukrust P, McEvoy LK, Djurovic S, Karlsen TH, Dale AM. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS One 2015;10:e0123057. [PMID: 25853426 DOI: 10.1371/journal.pone.0123057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
54 de Souza PM, Newson J, Gilroy DW. Targeting lipoxygenases with care. Chem Biol 2006;13:1121-2. [PMID: 17113992 DOI: 10.1016/j.chembiol.2006.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
55 Huang LM, Hu Q, Huang X, Qian Y, Lai XH. Preconditioning rats with three lipid emulsions prior to acute lung injury affects cytokine production and cell apoptosis in the lung and liver. Lipids Health Dis 2020;19:19. [PMID: 32024527 DOI: 10.1186/s12944-019-1137-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
56 Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273-1288. [PMID: 28087575 DOI: 10.1096/fj.201601222r] [Cited by in Crossref: 282] [Cited by in F6Publishing: 158] [Article Influence: 56.4] [Reference Citation Analysis]
57 Jannaway M, Torrens C, Warner JA, Sampson AP. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619. Br J Pharmacol 2018;175:1100-8. [PMID: 29352769 DOI: 10.1111/bph.14151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
58 Hong S, Lu Y. Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury. Front Immunol 2013;4:13. [PMID: 23386851 DOI: 10.3389/fimmu.2013.00013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
59 Arita M. Mediator lipidomics in acute inflammation and resolution. J Biochem. 2012;152:313-319. [PMID: 22923733 DOI: 10.1093/jb/mvs092] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 9.5] [Reference Citation Analysis]
60 El Kebir D, Gjorstrup P, Filep JG. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci USA. 2012;109:14983-14988. [PMID: 22927428 DOI: 10.1073/pnas.1206641109] [Cited by in Crossref: 159] [Cited by in F6Publishing: 158] [Article Influence: 15.9] [Reference Citation Analysis]
61 Kalsotra A, Du L, Wang Y, Ladd PA, Kikuta Y, Duvic M, Boyd AS, Keeney DS, Strobel HW. Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways. FASEB J 2008;22:538-47. [PMID: 17884973 DOI: 10.1096/fj.07-9244com] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
62 Calder PC. Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol 2009;28:506-34. [PMID: 19954361 DOI: 10.3109/08830180903197480] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
63 Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354-66. [DOI: 10.1038/mi.2012.24] [Cited by in Crossref: 320] [Cited by in F6Publishing: 311] [Article Influence: 32.0] [Reference Citation Analysis]
64 Haworth O, Levy BD. Lipoxins, resolvins and protectins: new leads for the treatment of asthma. Expert Opin Drug Discov 2008;3:1209-22. [PMID: 23489078 DOI: 10.1517/17460441.3.10.1209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Yilmaz M, Claiborn KC, Hotamisligil GS. De Novo Lipogenesis Products and Endogenous Lipokines. Diabetes 2016;65:1800-7. [PMID: 27288005 DOI: 10.2337/db16-0251] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
66 Wu Q, Purusram G, Wang H, Yuan R, Xie W, Gui P, Dong N, Yao S. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery. Br J Clin Pharmacol 2013;75:769-78. [PMID: 22835079 DOI: 10.1111/j.1365-2125.2012.04393.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Baidoo JNE, Mukherjee S, Kashfi K, Banerjee P. A New Perspective on Cancer Therapy: Changing the Treaded Path? Int J Mol Sci 2021;22:9836. [PMID: 34575998 DOI: 10.3390/ijms22189836] [Reference Citation Analysis]
68 Campbell EL, Serhan CN, Colgan SP. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol 2011;187:3475-81. [PMID: 21934099 DOI: 10.4049/jimmunol.1100150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
69 Gu Z, Shan K, Chen H, Chen YQ. n-3 Polyunsaturated Fatty Acids and their Role in Cancer Chemoprevention. Curr Pharmacol Rep 2015;1:283-94. [PMID: 26457243 DOI: 10.1007/s40495-015-0043-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
70 Das UN. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflamm Res. 2010;3:143-170. [PMID: 22096364 DOI: 10.2147/jir.s9425] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
71 Lang JE, Mougey EB, Allayee H, Blake KV, Lockey R, Gong Y, Hossain J, Killen K, Lima JJ; Nemours Network for Asthma Research. Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods. Contemp Clin Trials 2013;34:326-35. [PMID: 23298524 DOI: 10.1016/j.cct.2012.12.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
72 Ariel A, Li P, Wang W, Tang W, Fredman G, Hong S, Gotlinger KH, Serhan CN. The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering. Journal of Biological Chemistry 2005;280:43079-86. [DOI: 10.1074/jbc.m509796200] [Cited by in Crossref: 166] [Cited by in F6Publishing: 89] [Article Influence: 9.8] [Reference Citation Analysis]
73 Edwards JM, McCarthy CG, Wenceslau CF. The Obligatory Role of the Acetylcholine-Induced Endothelium-Dependent Contraction in Hypertension: Can Arachidonic Acid Resolve this Inflammation? Curr Pharm Des 2020;26:3723-32. [PMID: 32303165 DOI: 10.2174/1381612826666200417150121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
74 Stark DT, Bazan NG. Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J Neurosci 2011;31:13710-21. [PMID: 21957234 DOI: 10.1523/JNEUROSCI.3544-11.2011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
75 Pistorius K, Souza PR, De Matteis R, Austin-Williams S, Primdahl KG, Vik A, Mazzacuva F, Colas RA, Marques RM, Hansen TV, Dalli J. PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function. Cell Chem Biol 2018;25:749-760.e9. [PMID: 29805036 DOI: 10.1016/j.chembiol.2018.04.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
76 Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376:540-550. [PMID: 20638121 DOI: 10.1016/s0140-6736(10)60445-x] [Cited by in Crossref: 355] [Cited by in F6Publishing: 121] [Article Influence: 29.6] [Reference Citation Analysis]
77 Aoki H, Hisada T, Ishizuka T, Utsugi M, Ono A, Koga Y, Sunaga N, Nakakura T, Okajima F, Dobashi K, Mori M. Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun 2010;400:128-33. [PMID: 20708601 DOI: 10.1016/j.bbrc.2010.08.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
78 Fierro IM, Serhan CN. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. Braz J Med Biol Res. 2001;34:555-566. [PMID: 11323741 DOI: 10.1590/s0100-879x2001000500002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
79 Chiang N, Shinohara M, Dalli J, Mirakaj V, Kibi M, Choi AM, Serhan CN. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J Immunol 2013;190:6378-88. [PMID: 23650615 DOI: 10.4049/jimmunol.1202969] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 9.2] [Reference Citation Analysis]
80 Das UN. Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clinical Lipidology 2011;6:463-89. [DOI: 10.2217/clp.11.34] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
81 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
82 Carlo T, Levy BD. Chemical mediators and the resolution of airway inflammation. Allergol Int 2008;57:299-305. [PMID: 18946231 DOI: 10.2332/allergolint.08-RAI-0018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
83 Manohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Chronic Pancreatitis Associated Acute Respiratory Failure. MOJ Immunol 2017;5:00149. [PMID: 29399623 DOI: 10.15406/moji.2017.05.00149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
84 Dubé L, Spahis S, Lachaîne K, Lemieux A, Monhem H, Poulin S, Randoll C, Travaillaud E, Ould-chikh N, Marcil V, Delvin E, Levy E. SPECIALIZED PRO-RESOLVING MEDIATORS DERIVED FROM N-3 POLYUNSATURATED FATTY ACIDS: ROLE IN METABOLIC SYNDROME AND RELATED COMPLICATIONS. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0156] [Reference Citation Analysis]
85 Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 2011;437:185-97. [PMID: 21711247 DOI: 10.1042/BJ20110327] [Cited by in Crossref: 99] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
86 Haworth O, Buckley CD. Pathways involved in the resolution of inflammatory joint disease. Seminars in Immunology 2015;27:194-9. [DOI: 10.1016/j.smim.2015.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
87 Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet Immunol Immunopathol 2014;158:121-7. [PMID: 24556326 DOI: 10.1016/j.vetimm.2014.01.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
88 Nelson JR, Budoff MJ, Wani OR, Le V, Patel DK, Nelson A, Nemiroff RL. EPA's pleiotropic mechanisms of action: a narrative review. Postgrad Med 2021;133:651-64. [PMID: 33900135 DOI: 10.1080/00325481.2021.1921491] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Al-Jawadi A, Moussa H, Ramalingam L, Dharmawardhane S, Gollahon L, Gunaratne P, Layeequr Rahman R, Moustaid-Moussa N. Protective properties of n-3 fatty acids and implications in obesity-associated breast cancer. J Nutr Biochem 2018;53:1-8. [PMID: 29096149 DOI: 10.1016/j.jnutbio.2017.09.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
90 Norling LV, Perretti M. Control of myeloid cell trafficking in resolution. J Innate Immun 2013;5:367-76. [PMID: 23635943 DOI: 10.1159/000350612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
91 Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014;19:21-36. [PMID: 24239568 DOI: 10.1016/j.cmet.2013.10.006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 247] [Article Influence: 29.0] [Reference Citation Analysis]
92 Isobe Y, Itagaki M, Ito Y, Naoe S, Kojima K, Ikeguchi M, Arita M. Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. Sci Rep 2018;8:7954. [PMID: 29784972 DOI: 10.1038/s41598-018-26325-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
93 López-vicario C, Titos E, Walker ME, Alcaraz-quiles J, Casulleras M, Durán-güell M, Flores-costa R, Pérez-romero N, Forné M, Dalli J, Clària J. Leukocytes from obese individuals exhibit an impaired SPM signature. FASEB j 2019;33:7072-83. [DOI: 10.1096/fj.201802587r] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
94 Blaudez F, Ivanovski S, Fournier B, Vaquette C. The utilisation of resolvins in medicine and tissue engineering. Acta Biomater 2021:S1742-7061(21)00803-5. [PMID: 34875358 DOI: 10.1016/j.actbio.2021.11.047] [Reference Citation Analysis]
95 Carlo T, Levy BD. Molecular circuits of resolution in airway inflammation. ScientificWorldJournal 2010;10:1386-99. [PMID: 20623098 DOI: 10.1100/tsw.2010.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
96 Lopategi A, López-Vicario C, Alcaraz-Quiles J, García-Alonso V, Rius B, Titos E, Clària J. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol 2016;419:44-59. [PMID: 26433072 DOI: 10.1016/j.mce.2015.09.033] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
97 Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013;27:2220-2232. [PMID: 23407709 DOI: 10.1096/fj.12-225615] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 8.6] [Reference Citation Analysis]
98 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
99 Norling LV, Serhan CN. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010;268:15-24. [PMID: 20497301 DOI: 10.1111/j.1365-2796.2010.02235.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 31] [Article Influence: 0.7] [Reference Citation Analysis]
100 Wheatley C. The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS. J Nutr Environ Med 2007;16:181-211. [PMID: 18836533 DOI: 10.1080/10520290701791839] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
101 Uno H, Furukawa K, Suzuki D, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Immunonutrition suppresses acute inflammatory responses through modulation of resolvin E1 in patients undergoing major hepatobiliary resection. Surgery. 2016;160:228-236. [PMID: 26965712 DOI: 10.1016/j.surg.2016.01.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
102 Barnig C, Levy BD. Innate immunity is a key factor for the resolution of inflammation in asthma. Eur Respir Rev 2015;24:141-53. [PMID: 25726564 DOI: 10.1183/09059180.00012514] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
103 Iverson C, Bacong A, Liu S, Baumgartner S, Lundström T, Oscarsson J, Miner JN. Omega-3-carboxylic acids provide efficacious anti-inflammatory activity in models of crystal-mediated inflammation. Sci Rep 2018;8:1217. [PMID: 29352206 DOI: 10.1038/s41598-018-19252-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
104 Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 Fatty Acid-Derived Mediators 17( R )-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice. J I 2011;187:1957-69. [DOI: 10.4049/jimmunol.1101305] [Cited by in Crossref: 168] [Cited by in F6Publishing: 163] [Article Influence: 15.3] [Reference Citation Analysis]
105 Hisada T, Ishizuka T, Aoki H, Mori M. Resolvin E1 as a novel agent for the treatment of asthma. Expert Opin Ther Targets 2009;13:513-22. [PMID: 19368495 DOI: 10.1517/14728220902865622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
106 Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2007;77:327-35. [DOI: 10.1016/j.plefa.2007.10.015] [Cited by in Crossref: 254] [Cited by in F6Publishing: 227] [Article Influence: 16.9] [Reference Citation Analysis]
107 Vijay-Kumar M, Vanegas SM, Patel N, Aitken JD, Ziegler TR, Ganji V. Fish oil rich diet in comparison to saturated fat rich diet offered protection against lipopolysaccharide-induced inflammation and insulin resistance in mice. Nutr Metab (Lond) 2011;8:16. [PMID: 21388548 DOI: 10.1186/1743-7075-8-16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
108 Anderson BM, Ma DW. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis 2009;8:33. [PMID: 19664246 DOI: 10.1186/1476-511X-8-33] [Cited by in Crossref: 200] [Cited by in F6Publishing: 60] [Article Influence: 15.4] [Reference Citation Analysis]
109 Maciejewska-Markiewicz D, Stachowska E, Hawryłkowicz V, Stachowska L, Prowans P. The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD). Biomolecules 2021;11:937. [PMID: 34202667 DOI: 10.3390/biom11070937] [Reference Citation Analysis]
110 Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2016;107:24-9. [DOI: 10.1016/j.plefa.2016.03.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 11.8] [Reference Citation Analysis]
111 Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 2004;101:8491-6. [PMID: 15152078 DOI: 10.1073/pnas.0402531101] [Cited by in Crossref: 521] [Cited by in F6Publishing: 476] [Article Influence: 28.9] [Reference Citation Analysis]
112 Vik A, Hansen TV. Stereoselective syntheses and biological activities of E-series resolvins. Org Biomol Chem 2021;19:705-21. [PMID: 33410452 DOI: 10.1039/d0ob02218g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Havixbeck JJ, Barreda DR. Neutrophil Development, Migration, and Function in Teleost Fish. Biology (Basel) 2015;4:715-34. [PMID: 26561837 DOI: 10.3390/biology4040715] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
114 Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355-374. [PMID: 22254027 DOI: 10.3390/nu2030355] [Cited by in Crossref: 409] [Cited by in F6Publishing: 371] [Article Influence: 34.1] [Reference Citation Analysis]
115 Barabino S, Horwath-Winter J, Messmer EM, Rolando M, Aragona P, Kinoshita S. The role of systemic and topical fatty acids for dry eye treatment. Prog Retin Eye Res 2017;61:23-34. [PMID: 28532687 DOI: 10.1016/j.preteyeres.2017.05.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
116 Holm T, Berge RK, Andreassen AK, Ueland T, Kjekshus J, Simonsen S, Fr??land S, Gullestad L, Aukrust P. OMEGA-3 FATTY ACIDS ENHANCE TUMOR NECROSIS FACTOR-?? LEVELS IN HEART TRANSPLANT RECIPIENTS: . Transplantation 2001;72:706-11. [DOI: 10.1097/00007890-200108270-00025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
117 Heinz J, Marinello M, Fredman G. Pro-resolution therapeutics for cardiovascular diseases. Prostaglandins & Other Lipid Mediators 2017;132:12-6. [DOI: 10.1016/j.prostaglandins.2017.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
118 Serhan CN. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids. 2008;79:157-163. [PMID: 19008087 DOI: 10.1016/j.plefa.2008.09.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
119 Dragano NRV, Solon C, Ramalho AF, de Moura RF, Razolli DS, Christiansen E, Azevedo C, Ulven T, Velloso LA. Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation. J Neuroinflammation 2017;14:91. [PMID: 28446241 DOI: 10.1186/s12974-017-0869-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
120 Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. Journal of Thrombosis and Haemostasis 2009;7:44-8. [DOI: 10.1111/j.1538-7836.2009.03396.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
121 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
122 Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA Jr. Specialized pro-resolving lipid mediators: A new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res 2020;151:104549. [PMID: 31743775 DOI: 10.1016/j.phrs.2019.104549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
123 Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA. 2010;107:14298-14303. [PMID: 20660763 DOI: 10.1073/pnas.0914730107] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 10.6] [Reference Citation Analysis]
124 Ni CM, Yang W, Wan KS. Serum levels of lipoxin A(4) do not predict the development of subsequent asthma among young children with acute bronchiolitis. J Asthma 2011;48:576-80. [PMID: 21671842 DOI: 10.3109/02770903.2011.587582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
125 Huang J, Burston JJ, Li L, Ashraf S, Mapp PI, Bennett AJ, Ravipati S, Pousinis P, Barrett DA, Scammell BE, Chapman V. Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain. Arthritis Rheumatol 2017;69:996-1008. [PMID: 27860453 DOI: 10.1002/art.40001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
126 Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005;174:4345-55. [PMID: 15778399 DOI: 10.4049/jimmunol.174.7.4345] [Cited by in Crossref: 479] [Cited by in F6Publishing: 456] [Article Influence: 28.2] [Reference Citation Analysis]
127 Rey C, Nadjar A, Joffre F, Amadieu C, Aubert A, Vaysse C, Pallet V, Layé S, Joffre C. Maternal n-3 polyunsaturated fatty acid dietary supply modulates microglia lipid content in the offspring. Prostaglandins, Leukotrienes and Essential Fatty Acids 2018;133:1-7. [DOI: 10.1016/j.plefa.2018.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
128 Khaled M, Shibani NA, Labban N, Batarseh G, Song F, Ruby J, Windsor LJ. Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. J Periodontol 2013;84:1838-46. [PMID: 23398023 DOI: 10.1902/jop.2013.120388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
129 Korosh T, Jordan KD, Wu JS, Yarlett N, Upmacis RK. Eicosapentaenoic Acid Modulates Trichomonas vaginalis Activity. J Eukaryot Microbiol 2016;63:153-61. [PMID: 26333486 DOI: 10.1111/jeu.12263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Norling LV, Dalli J, Flower RJ, Serhan CN, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol 2012;32:1970-8. [PMID: 22499990 DOI: 10.1161/ATVBAHA.112.249508] [Cited by in Crossref: 166] [Cited by in F6Publishing: 124] [Article Influence: 16.6] [Reference Citation Analysis]
131 Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008;9:873-9. [PMID: 18568027 DOI: 10.1038/ni.1627] [Cited by in Crossref: 305] [Cited by in F6Publishing: 278] [Article Influence: 21.8] [Reference Citation Analysis]
132 Kostoglou-Athanassiou I, Athanassiou L, Athanassiou P. The Effect of Omega-3 Fatty Acids on Rheumatoid Arthritis. Mediterr J Rheumatol 2020;31:190-4. [PMID: 32676556 DOI: 10.31138/mjr.31.2.190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Chen WT, Chen SY, Wu DW, Lee CC, Lee TM. Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120-mediated connexin43 phosphorylation. J Cell Mol Med 2020;24:9267-79. [PMID: 32639107 DOI: 10.1111/jcmm.15575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
134 Mowry FE, Biancardi VC. Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways. Pharmacol Res 2019;144:279-91. [PMID: 31039397 DOI: 10.1016/j.phrs.2019.04.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
135 Titos E, Clària J. Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation. Prostaglandins Other Lipid Mediat 2013;107:77-84. [PMID: 23707933 DOI: 10.1016/j.prostaglandins.2013.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
136 Johnson KM, Weinhold KR, Andridge R, Arnold K, Chu PP, Orchard TS. Associations of Erythrocyte Polyunsaturated Fatty Acids with Inflammation and Quality of Life in Post-Menopausal Women with Obesity Completing a Pilot Dietary Intervention. Nutrients 2019;11:E1589. [PMID: 31337035 DOI: 10.3390/nu11071589] [Reference Citation Analysis]
137 Oh SF, Pillai PS, Recchiuti A, Yang R, Serhan CN. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J Clin Invest. 2011;121:569-581. [PMID: 21206090 DOI: 10.1172/jci42545] [Cited by in Crossref: 186] [Cited by in F6Publishing: 120] [Article Influence: 16.9] [Reference Citation Analysis]
138 Lee JY, Han SH, Park MH, Baek B, Song IS, Choi MK, Takuwa Y, Ryu H, Kim SH, He X, Schuchman EH, Bae JS, Jin HK. Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. Nat Commun 2018;9:1479. [PMID: 29662056 DOI: 10.1038/s41467-018-03674-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
139 Xie W, Wang H, Wang L, Yao C, Yuan R, Wu Q. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. Lab Invest 2013;93:991-1000. [PMID: 23857007 DOI: 10.1038/labinvest.2013.80] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
140 Wu MY, Chen CS, Yiang GT, Cheng PW, Chen YL, Chiu HC, Liu KH, Lee WC, Li CJ. The Emerging Role of Pathogenesis of IgA Nephropathy. J Clin Med 2018;7:E225. [PMID: 30127305 DOI: 10.3390/jcm7080225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
141 Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN. Anesthetics impact the resolution of inflammation. PLoS One 2008;3:e1879. [PMID: 18382663 DOI: 10.1371/journal.pone.0001879] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
142 Nesman JI, Tungen JE, Vik A, Hansen TV. Stereoselective synthesis of the specialized pro-resolving and anti-inflammatory mediator resolvin E1. Tetrahedron 2020;76:130821. [DOI: 10.1016/j.tet.2019.130821] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
143 Silva AR, Moraes BPT, Gonçalves-de-Albuquerque CF. Mediterranean Diet: Lipids, Inflammation, and Malaria Infection. Int J Mol Sci 2020;21:E4489. [PMID: 32599864 DOI: 10.3390/ijms21124489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
144 Greene ER, Huang S, Serhan CN, Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 2011;96:27-36. [PMID: 21864702 DOI: 10.1016/j.prostaglandins.2011.08.004] [Cited by in Crossref: 182] [Cited by in F6Publishing: 179] [Article Influence: 16.5] [Reference Citation Analysis]
145 Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis. 2011;10:76. [PMID: 21569625 DOI: 10.1186/1476-511x-10-76] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
146 Easley JT, Maruyama CL, Wang CS, Baker OJ. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium. Physiol Rep 2016;4:e12990. [PMID: 27694530 DOI: 10.14814/phy2.12990] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
147 Jones ML, Mark PJ, Keelan JA, Barden A, Mas E, Mori TA, Waddell BJ. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J Lipid Res 2013;54:2247-54. [PMID: 23723388 DOI: 10.1194/jlr.M039842] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
148 Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 2010;26:431-9. [PMID: 20874497 DOI: 10.1089/jop.2010.0019] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
149 Gao L, Yin H, Milne GL, Porter NA, Morrow JD. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem. 2006;281:14092-14099. [PMID: 16569632 DOI: 10.1074/jbc.m601035200] [Cited by in Crossref: 101] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
150 Lobo BW, Lima CKF, Teixeira MS, Silva NL, Takiya CM, Ramos MF, Miranda ALP, Dellamora-ortiz GM. Fish oil attenuates persistent inflammatory pain in rats through modulation of TNF-α and resolvins. Life Sciences 2016;152:30-7. [DOI: 10.1016/j.lfs.2016.03.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
151 Colgan SP. Resolvins resolve to heal mucosal wounds. Proc Natl Acad Sci U S A 2020;117:10621-2. [PMID: 32371481 DOI: 10.1073/pnas.2005652117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol 2020;11:599853. [PMID: 33324417 DOI: 10.3389/fimmu.2020.599853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Das UN. Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? Front Endocrinol (Lausanne) 2017;8:182. [PMID: 28824543 DOI: 10.3389/fendo.2017.00182] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
154 Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Föcking M, Cotter D, Amminger GP. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial. Brain Behav Immun 2021;99:147-56. [PMID: 34624483 DOI: 10.1016/j.bbi.2021.09.018] [Reference Citation Analysis]
155 Hromcik F, Vokurka J, Gopfert E, Faldyna M, Hermanova M, Kyr M, Vicenova M, Izakovicova Holla L. Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021;165:216-23. [PMID: 32091012 DOI: 10.5507/bp.2020.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Taguchi A, Yamashita A, Kawana K, Nagamatsu T, Furuya H, Inoue E, Osuga Y, Fujii T. Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review. Reprod Sci 2016;24:7-18. [DOI: 10.1177/1933719115618282] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
157 Pino AM, Rodríguez JP. Is fatty acid composition of human bone marrow significant to bone health? Bone 2019;118:53-61. [DOI: 10.1016/j.bone.2017.12.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
158 Scoditti E, Capurso C, Capurso A, Massaro M. Vascular effects of the Mediterranean diet-part II: role of omega-3 fatty acids and olive oil polyphenols. Vascul Pharmacol 2014;63:127-34. [PMID: 25446163 DOI: 10.1016/j.vph.2014.07.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
159 Bravo E, Napolitano M, Valentini SB, Quattrucci S. Neutrophil unsaturated fatty acid release by GM-CSF is impaired in cystic fibrosis. Lipids Health Dis 2010;9:129. [PMID: 21059219 DOI: 10.1186/1476-511X-9-129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
160 Lannan KL, Spinelli SL, Blumberg N, Phipps RP. Maresin 1 induces a novel pro-resolving phenotype in human platelets. J Thromb Haemost 2017;15:802-13. [PMID: 28079976 DOI: 10.1111/jth.13620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
161 Gc JB, Szlenk CT, Gao J, Dong X, Wang Z, Natesan S. Molecular Dynamics Simulations Provide Insight into the Loading Efficiency of Proresolving Lipid Mediators Resolvin D1 and D2 in Cell Membrane-Derived Nanovesicles. Mol Pharm 2020;17:2155-64. [PMID: 32374613 DOI: 10.1021/acs.molpharmaceut.0c00299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Benabdoune H, Rondon EP, Shi Q, Fernandes J, Ranger P, Fahmi H, Benderdour M. The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. Inflamm Res 2016;65:635-45. [PMID: 27056390 DOI: 10.1007/s00011-016-0946-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
163 Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics 2014;141:272-82. [DOI: 10.1016/j.pharmthera.2013.10.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 188] [Article Influence: 26.5] [Reference Citation Analysis]
164 Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med. 2008;14:461-469. [PMID: 18774339 DOI: 10.1016/j.molmed.2008.08.005] [Cited by in Crossref: 348] [Cited by in F6Publishing: 324] [Article Influence: 24.9] [Reference Citation Analysis]
165 Lizewska B, Teul J, Kuc P, Lemancewicz A, Charkiewicz K, Goscik J, Kacerovsky M, Menon R, Miltyk W, Laudanski P. Maternal Plasma Metabolomic Profiles in Spontaneous Preterm Birth: Preliminary Results. Mediators Inflamm 2018;2018:9362820. [PMID: 29670470 DOI: 10.1155/2018/9362820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
166 Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 2018;19:654-72. [PMID: 30104701 DOI: 10.1038/s41580-018-0044-8] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 38.3] [Reference Citation Analysis]
167 Levy BD. Resolvins and protectins: natural pharmacophores for resolution biology. Prostaglandins Leukot Essent Fatty Acids 2010;82:327-32. [PMID: 20227865 DOI: 10.1016/j.plefa.2010.02.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
168 Anthonymuthu TS, Kenny EM, Bayır H. Therapies targeting lipid peroxidation in traumatic brain injury. Brain Res 2016;1640:57-76. [PMID: 26872597 DOI: 10.1016/j.brainres.2016.02.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
169 Demler OV, Liu Y, Luttmann-Gibson H, Watrous JD, Lagerborg KA, Dashti H, Giulianini F, Heath M, Camargo CA Jr, Harris WS, Wohlgemuth JG, Andres AM, Tivari S, Long T, Najhawan M, Dao K, Prentice JG, Larsen JA, Okereke OI, Costenbader KH, Buring JE, Manson JE, Cheng S, Jain M, Mora S. One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL). Metabolites 2020;10:E431. [PMID: 33120862 DOI: 10.3390/metabo10110431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
170 Vassiliou EK, Kesler OM, Tadros JH, Ganea D. Bone Marrow-Derived Dendritic Cells Generated in the Presence of Resolvin E1 Induce Apoptosis of Activated CD4 + T Cells. J Immunol 2008;181:4534-44. [DOI: 10.4049/jimmunol.181.7.4534] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
171 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
172 Masoodi M, Mir AA, Petasis NA, Serhan CN, Nicolaou A. Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:75-83. [PMID: 18059001 DOI: 10.1002/rcm.3331] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 7.6] [Reference Citation Analysis]
173 Cash JL, White GE, Greaves DR. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol 2009;461:379-96. [PMID: 19480928 DOI: 10.1016/S0076-6879(09)05417-2] [Cited by in Crossref: 80] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
174 Kim AS, Conte MS. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Advanced Drug Delivery Reviews 2020;159:170-9. [DOI: 10.1016/j.addr.2020.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
175 Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukot Essent Fatty Acids 2021;164:102219. [PMID: 33316626 DOI: 10.1016/j.plefa.2020.102219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
176 Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011;34:599-609. [PMID: 21963090 DOI: 10.1016/j.tins.2011.08.005] [Cited by in Crossref: 207] [Cited by in F6Publishing: 198] [Article Influence: 18.8] [Reference Citation Analysis]
177 Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885-897. [PMID: 18504706 DOI: 10.1002/mnfr.200700289] [Cited by in Crossref: 293] [Cited by in F6Publishing: 268] [Article Influence: 20.9] [Reference Citation Analysis]
178 Hirahashi J. Omega-3 Polyunsaturated Fatty Acids for the Treatment of IgA Nephropathy. J Clin Med 2017;6:E70. [PMID: 28753924 DOI: 10.3390/jcm6070070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
179 Sharma NP, Dong L, Yuan C, Noon KR, Smith WL. Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. Mol Pharmacol. 2010;77:979-986. [PMID: 20194532 DOI: 10.1124/mol.109.063115] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
180 Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922-43. [PMID: 21766791 DOI: 10.1021/cr100396c] [Cited by in Crossref: 607] [Cited by in F6Publishing: 560] [Article Influence: 55.2] [Reference Citation Analysis]
181 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
182 Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 2010;177:2116-23. [PMID: 20709806 DOI: 10.2353/ajpath.2010.091082] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 10.9] [Reference Citation Analysis]
183 Chouinard-Watkins R, Rioux-Perreault C, Fortier M, Tremblay-Mercier J, Zhang Y, Lawrence P, Vohl MC, Perron P, Lorrain D, Brenna JT, Cunnane SC, Plourde M. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele. Br J Nutr 2013;110:1751-9. [PMID: 23631810 DOI: 10.1017/S0007114513001268] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
184 Dornelles FN, Santos DS, Van Dyke TE, Calixto JB, Batista EL, Campos MM. In Vivo Up-Regulation of Kinin B 1 Receptors after Treatment with Porphyromonas gingivalis Lipopolysaccharide in Rat Paw. J Pharmacol Exp Ther 2009;330:756-63. [DOI: 10.1124/jpet.109.155762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
185 Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008;367:509-15. [PMID: 18190790 DOI: 10.1016/j.bbrc.2008.01.012] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 8.5] [Reference Citation Analysis]
186 Calder PC. Fatty acids and inflammation: The cutting edge between food and pharma. European Journal of Pharmacology 2011;668:S50-8. [DOI: 10.1016/j.ejphar.2011.05.085] [Cited by in Crossref: 286] [Cited by in F6Publishing: 252] [Article Influence: 26.0] [Reference Citation Analysis]
187 Sismanoglu S, Ercal P. Dentin-Pulp Tissue Regeneration Approaches in Dentistry: An Overview and Current Trends. Adv Exp Med Biol 2020;1298:79-103. [PMID: 32902726 DOI: 10.1007/5584_2020_578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
188 Rodríguez MJ, Herrera F, Donoso W, Castillo I, Orrego R, González DR, Zúñiga-Hernández J. Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation. Int J Mol Sci 2020;21:E8827. [PMID: 33266360 DOI: 10.3390/ijms21228827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Maskrey BH, Megson IL, Whitfield PD, Rossi AG. Mechanisms of Resolution of Inflammation: A Focus on Cardiovascular Disease. ATVB 2011;31:1001-6. [DOI: 10.1161/atvbaha.110.213850] [Cited by in Crossref: 101] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
190 Chiu CY, Smyl C, Dogan I, Rothe M, Weylandt KH. Quantitative Profiling of Hydroxy Lipid Metabolites in Mouse Organs Reveals Distinct Lipidomic Profiles and Modifications Due to Elevated n-3 Fatty Acid Levels. Biology (Basel) 2017;6:E9. [PMID: 28165385 DOI: 10.3390/biology6010009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
191 Makriyannis A, Nikas SP. Aspirin-triggered metabolites of EFAs. Chem Biol 2011;18:1208-9. [PMID: 22035788 DOI: 10.1016/j.chembiol.2011.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
192 Marino M, Masella R, Bulzomi P, Campesi I, Malorni W, Franconi F. Nutrition and human health from a sex-gender perspective. Mol Aspects Med 2011;32:1-70. [PMID: 21356234 DOI: 10.1016/j.mam.2011.02.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
193 Bassaganya-riera J, Hontecillas R, Wannemuehler MJ. Nutrition impact of conjugated linoleic acid: A model functional food ingredient. In Vitro Cell Dev Biol - Plant 2002;38:241-6. [DOI: 10.1079/ivp2002295] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
194 Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from ω-3 polyunsaturated fatty acids. Biochemical and Biophysical Research Communications 2005;338:149-57. [DOI: 10.1016/j.bbrc.2005.07.181] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
195 Luo B, Wang J, Liu Z, Shen Z, Shi R, Liu YQ, Liu Y, Jiang M, Wu Y, Zhang Z. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. Nat Commun 2016;7:12177. [PMID: 27397585 DOI: 10.1038/ncomms12177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
196 Norris PC, Libreros S, Chiang N, Serhan CN. A cluster of immunoresolvents links coagulation to innate host defense in human blood. Sci Signal 2017;10:eaan1471. [PMID: 28765512 DOI: 10.1126/scisignal.aan1471] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
197 Maksymowych WP, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. Fat Metaplasia and Backfill Are Key Intermediaries in the Development of Sacroiliac Joint Ankylosis in Patients With Ankylosing Spondylitis: Development of SI Joint Ankylosis in Patients With AS. Arthritis & Rheumatology 2014;66:2958-67. [DOI: 10.1002/art.38792] [Cited by in Crossref: 79] [Cited by in F6Publishing: 62] [Article Influence: 9.9] [Reference Citation Analysis]
198 Roy J, Vigor C, Vercauteren J, Reversat G, Zhou B, Surget A, Larroquet L, Lanuque A, Sandres F, Terrier F, Oger C, Galano JM, Corraze G, Durand T. Characterization and modulation of brain lipids content of rainbow trout fed with 100% plant based diet rich in omega-3 long chain polyunsaturated fatty acids DHA and EPA. Biochimie 2020;178:137-47. [PMID: 32623048 DOI: 10.1016/j.biochi.2020.06.010] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
199 Tungen JE, Aursnes M, Vik A, Ramon S, Colas RA, Dalli J, Serhan CN, Hansen TV. Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1. J Nat Prod 2014;77:2241-7. [PMID: 25247845 DOI: 10.1021/np500498j] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
200 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
201 Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53. [PMID: 12678571 DOI: 10.2165/00003495-200363090-00001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
202 Tiberi M, Chiurchiù V. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair. Front Cell Neurosci 2021;15:673549. [PMID: 33981203 DOI: 10.3389/fncel.2021.673549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
203 Tangeten C, Zouaoui Boudjeltia K, Delporte C, Van Antwerpen P, Korpak K. Unexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution. Antioxidants 2022;11:874. [DOI: 10.3390/antiox11050874] [Reference Citation Analysis]
204 Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-40. [PMID: 23747022 DOI: 10.1016/j.coph.2013.05.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
205 Shinohara M, Mirakaj V, Serhan CN. Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome. Front Immunol 2012;3:81. [PMID: 22566962 DOI: 10.3389/fimmu.2012.00081] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
206 Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361. [PMID: 18437155 DOI: 10.1038/nri2294] [Cited by in Crossref: 1820] [Cited by in F6Publishing: 1699] [Article Influence: 130.0] [Reference Citation Analysis]
207 Serhan CN, Hong S, Lu Y. Lipid mediator informatics-lipidomics: novel pathways in mapping resolution. AAPS J 2006;8:E284-97. [PMID: 16796379 DOI: 10.1007/BF02854899] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
208 Fredman G, Van Dyke TE, Serhan CN. Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol 2010;30:2005-13. [PMID: 20702811 DOI: 10.1161/ATVBAHA.110.209908] [Cited by in Crossref: 73] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
209 Velloso LA, Folli F, Saad MJ. TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation. Endocr Rev. 2015;36:245-271. [PMID: 25811237 DOI: 10.1210/er.2014-1100] [Cited by in Crossref: 141] [Cited by in F6Publishing: 136] [Article Influence: 20.1] [Reference Citation Analysis]
210 Kelavkar UP, Hutzley J, Dhir R, Kim P, Allen KG, McHugh K. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 2006;8:112-24. [PMID: 16611404 DOI: 10.1593/neo.05637] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
211 Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, McEvoy N, McElvaney OJ, McElvaney O, Alalqam R, McElvaney NG, Curley GF, Dalli J. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One 2021;16:e0256226. [PMID: 34437568 DOI: 10.1371/journal.pone.0256226] [Reference Citation Analysis]
212 Levy BD, Serhan CN. Resolution of acute inflammation in the lung. Annu Rev Physiol 2014;76:467-92. [PMID: 24313723 DOI: 10.1146/annurev-physiol-021113-170408] [Cited by in Crossref: 168] [Cited by in F6Publishing: 151] [Article Influence: 18.7] [Reference Citation Analysis]
213 Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem. 2012;287:10525-10534. [PMID: 22275352 DOI: 10.1074/jbc.m112.340612] [Cited by in Crossref: 151] [Cited by in F6Publishing: 84] [Article Influence: 15.1] [Reference Citation Analysis]
214 Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263. [PMID: 34248142 DOI: 10.1038/s41392-021-00658-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
215 Calder PC. Long-chain fatty acids and inflammation. Proc Nutr Soc 2012;71:284-9. [DOI: 10.1017/s0029665112000067] [Cited by in Crossref: 100] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
216 Fonseca FC, Orlando RM, Turchetti-Maia RM, de Francischi JN. Comparative effects of the ω3 polyunsaturated fatty acid derivatives resolvins E1 and D1 and protectin DX in models of inflammation and pain. J Inflamm Res 2017;10:119-33. [PMID: 28919798 DOI: 10.2147/JIR.S142424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
217 Weylandt KH. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell. Eur J Pharmacol 2016;785:108-15. [PMID: 26546723 DOI: 10.1016/j.ejphar.2015.11.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
218 Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, Hong S, Arita M, Serhan CN. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol. 2006;13:1193-1202. [PMID: 17114001 DOI: 10.1016/j.chembiol.2006.09.011] [Cited by in Crossref: 165] [Cited by in F6Publishing: 147] [Article Influence: 11.0] [Reference Citation Analysis]
219 Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J. 2006;1:420-439. [PMID: 16892270 DOI: 10.1002/biot.200600012] [Cited by in Crossref: 361] [Cited by in F6Publishing: 317] [Article Influence: 22.6] [Reference Citation Analysis]
220 Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006;75:197-202. [PMID: 16828270 DOI: 10.1016/j.plefa.2006.05.012] [Cited by in Crossref: 335] [Cited by in F6Publishing: 289] [Article Influence: 20.9] [Reference Citation Analysis]
221 Hellmann J, Tang Y, Spite M. Proresolving lipid mediators and diabetic wound healing. Curr Opin Endocrinol Diabetes Obes 2012;19:104-8. [PMID: 22374140 DOI: 10.1097/MED.0b013e3283514e00] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
222 Demarquoy J, Borgne FL. Biosynthesis, metabolism and function of protectins and resolvins. Clinical Lipidology 2014;9:683-93. [DOI: 10.2217/clp.14.44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
223 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
224 Lee H, Surh Y. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochemical Pharmacology 2012;84:1340-50. [DOI: 10.1016/j.bcp.2012.08.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
225 Chen J, Purvis GSD, Collotta D, Al Zoubi S, Sugimoto MA, Cacace A, Martin L, Colas RA, Collino M, Dalli J, Thiemermann C. RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance. Front Immunol 2020;11:2080. [PMID: 32983159 DOI: 10.3389/fimmu.2020.02080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
226 Fu T, Mohan M, Brennan EP, Woodman OL, Godson C, Kantharidis P, Ritchie RH, Qin CX. Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease. ACS Pharmacol Transl Sci 2020;3:43-55. [PMID: 32259087 DOI: 10.1021/acsptsci.9b00097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
227 Weylandt KH, Chiu C, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators 2012;97:73-82. [DOI: 10.1016/j.prostaglandins.2012.01.005] [Cited by in Crossref: 173] [Cited by in F6Publishing: 156] [Article Influence: 17.3] [Reference Citation Analysis]
228 Decker C, Sadhu S, Fredman G. Pro-Resolving Ligands Orchestrate Phagocytosis. Front Immunol 2021;12:660865. [PMID: 34177900 DOI: 10.3389/fimmu.2021.660865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 2004;122:305-21. [PMID: 15322859 DOI: 10.1007/s00418-004-0695-8] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 6.1] [Reference Citation Analysis]
230 Lu Y, Tian H, Hong S. Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J Lipid Res 2010;51:923-32. [PMID: 19965612 DOI: 10.1194/jlr.M000059] [Cited by in Crossref: 50] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
231 Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 2006;24:341-64. [PMID: 16927933 DOI: 10.1016/j.atc.2006.01.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
232 Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007;76:251-68. [PMID: 17466497 DOI: 10.1016/j.plefa.2007.03.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
233 Winkler JW, Uddin J, Serhan CN, Petasis NA. Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer. Org Lett 2013;15:1424-7. [PMID: 23510485 DOI: 10.1021/ol400484u] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
234 Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201:713-722. [PMID: 15753205 DOI: 10.1084/jem.20042031] [Cited by in Crossref: 630] [Cited by in F6Publishing: 584] [Article Influence: 37.1] [Reference Citation Analysis]
235 Dakin SG. A review of the healing processes in equine superficial digital flexor tendinopathy. Equine Vet Educ 2017;29:516-20. [DOI: 10.1111/eve.12572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
236 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
237 Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr. 2006;25:454-465. [PMID: 16698153 DOI: 10.1016/j.clnu.2005.12.008] [Cited by in Crossref: 157] [Cited by in F6Publishing: 134] [Article Influence: 9.8] [Reference Citation Analysis]
238 Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153 Suppl 1:S200-S215. [PMID: 17965751 DOI: 10.1038/sj.bjp.0707489] [Cited by in Crossref: 217] [Cited by in F6Publishing: 235] [Article Influence: 14.5] [Reference Citation Analysis]
239 Morin C, Fortin S, Cantin AM, Rousseau É. Docosahexaenoic Acid Derivative Prevents Inflammation and Hyperreactivity in Lung: Implication of PKC-Potentiated Inhibitory Protein for Heterotrimeric Myosin Light Chain Phosphatase of 17 kD in Asthma. Am J Respir Cell Mol Biol 2011;45:366-75. [DOI: 10.1165/rcmb.2010-0156oc] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
240 Calder PC. n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition 2006;83:1505S-19S. [DOI: 10.1093/ajcn/83.6.1505s] [Cited by in Crossref: 1536] [Cited by in F6Publishing: 552] [Article Influence: 96.0] [Reference Citation Analysis]
241 Siddiqui YD, Omori K, Ito T, Yamashiro K, Nakamura S, Okamoto K, Ono M, Yamamoto T, Van Dyke TE, Takashiba S. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis. Front Immunol 2019;10:307. [PMID: 30863409 DOI: 10.3389/fimmu.2019.00307] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
242 Wang CS, Maruyama CL, Easley JT, Trump BG, Baker OJ. AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice. Sci Rep 2017;7:45525. [PMID: 28361884 DOI: 10.1038/srep45525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
243 Simón MV, Agnolazza DL, German OL, Garelli A, Politi LE, Agbaga MP, Anderson RE, Rotstein NP. Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress. J Neurochem 2016;136:931-46. [PMID: 26662863 DOI: 10.1111/jnc.13487] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
244 Roy S, Das A, Sen CK. Disorder of Localized Inflammation in Wound Healing: A Systems Perspective. In: Vodovotz Y, An G, editors. Complex Systems and Computational Biology Approaches to Acute Inflammation. New York: Springer; 2013. pp. 173-83. [DOI: 10.1007/978-1-4614-8008-2_10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
245 Keinan D, Leigh NJ, Nelson JW, De Oleo L, Baker OJ. Understanding resolvin signaling pathways to improve oral health. Int J Mol Sci 2013;14:5501-18. [PMID: 23528855 DOI: 10.3390/ijms14035501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
246 Serhan CN, de la Rosa X, Jouvene C. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. J Intern Med 2019;286:240-58. [PMID: 30565762 DOI: 10.1111/joim.12871] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
247 Tippin BL, Levine AJ, Materi AM, Song WL, Keku TO, Goodman JE, Sansbury LB, Das S, Dai A, Kwong AM, Lin AM, Lin JM, Park JM, Patterson RE, Chlebowski RT, Garavito RM, Inoue T, Cho W, Lawson JA, Kapoor S, Kolonel LN, Le Marchand L, Haile RW, Sandler RS, Lin HJ. Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer. Prostaglandins Other Lipid Mediat 2012;97:22-8. [PMID: 21821144 DOI: 10.1016/j.prostaglandins.2011.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
248 Bassaganya-Riera J, Hontecillas R. Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2010;13:569-73. [PMID: 20508519 DOI: 10.1097/MCO.0b013e32833b648e] [Cited by in Crossref: 66] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
249 Herová M, Schmid M, Gemperle C, Hersberger M. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J Immunol 2015;194:2330-7. [PMID: 25637017 DOI: 10.4049/jimmunol.1402166] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 11.4] [Reference Citation Analysis]
250 Han YH, Lee K, Saha A, Han J, Choi H, Noh M, Lee YH, Lee MO. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. Biomol Ther (Seoul) 2021;29:455-64. [PMID: 34162770 DOI: 10.4062/biomolther.2021.094] [Reference Citation Analysis]
251 Hasturk H, Kantarci A, Van Dyke TE. Paradigm shift in the pharmacological management of periodontal diseases. Front Oral Biol 2012;15:160-76. [PMID: 22142963 DOI: 10.1159/000329678] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
252 Carion TW, Greenwood M, Ebrahim AS, Jerome A, Suvas S, Gronert K, Berger EA. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis. FASEB J 2018;32:5026-38. [PMID: 29913556 DOI: 10.1096/fj.201701502R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
253 Shimizu T, Saito T, Aoki-Saito H, Okada S, Ikeda H, Nakakura T, Fukuda H, Arai S, Fujiwara K, Nakajima Y, Horiguchi K, Yamada S, Ishida E, Hisada T, Shuto S, Yamada M. Resolvin E3 ameliorates high-fat diet-induced insulin resistance via the phosphatidylinositol-3-kinase/Akt signaling pathway in adipocytes. FASEB J 2022;36:e22188. [PMID: 35129868 DOI: 10.1096/fj.202100053R] [Reference Citation Analysis]
254 Kuksis A, Suomela J, Tarvainen M, Kallio H. Lipidomic Analysis of Glycerolipid and Cholesteryl Ester Autooxidation Products. Mol Biotechnol 2009;42:224-68. [DOI: 10.1007/s12033-009-9146-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
255 Joffre C, Dinel AL, Chataigner M, Pallet V, Layé S. n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging. Nutrients 2020;12:E647. [PMID: 32121189 DOI: 10.3390/nu12030647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
256 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
257 Sancéau JY, Maltais R, Poirier D, Marette A. Total Synthesis of the Antidiabetic (Type 2) Lipid Mediator Protectin DX/PDX. J Org Chem 2019;84:495-505. [PMID: 30586310 DOI: 10.1021/acs.joc.8b01973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
258 Isobe Y, Kato T, Arita M. Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol 2012;3:270. [PMID: 22973272 DOI: 10.3389/fimmu.2012.00270] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
259 Wang B, Wei J, Huangfu Q, Gao F, Qin L, Zhong J, Wen J, Ye Z, Yang X, Liu H, Xiao Y. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/4345037] [Reference Citation Analysis]
260 Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandins Leukot Essent Fatty Acids 2013;89:153-8. [PMID: 23602846 DOI: 10.1016/j.plefa.2013.02.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
261 Naqvi RA, Gupta M, George A, Naqvi AR. MicroRNAs in shaping the resolution phase of inflammation. Semin Cell Dev Biol 2021:S1084-9521(21)00066-5. [PMID: 33934990 DOI: 10.1016/j.semcdb.2021.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
262 Mayer K, Seeger W. Fish oil in critical illness: . Current Opinion in Clinical Nutrition and Metabolic Care 2008;11:121-7. [DOI: 10.1097/mco.0b013e3282f4cdc6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
263 Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ, Connor KM, Aderman CM, Liclican E, Carughi A, Perelman D, Kanaoka Y, Sangiovanni JP, Gronert K, Smith LE. 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med 2011;3:69ra12. [PMID: 21307302 DOI: 10.1126/scitranslmed.3001571] [Cited by in Crossref: 149] [Cited by in F6Publishing: 150] [Article Influence: 13.5] [Reference Citation Analysis]
264 Dalli J, Serhan C. Macrophage Proresolving Mediators-the When and Where. Microbiol Spectr 2016;4. [PMID: 27337457 DOI: 10.1128/microbiolspec.MCHD-0001-2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
265 Stein K, Stoffels M, Lysson M, Schneiker B, Dewald O, Krönke G, Kalff JC, Wehner S. A role for 12/15-lipoxygenase-derived proresolving mediators in postoperative ileus: protectin DX-regulated neutrophil extravasation. J Leukoc Biol 2016;99:231-9. [PMID: 26292977 DOI: 10.1189/jlb.3HI0515-189R] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
266 Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008;3:279-312. [PMID: 18233953 DOI: 10.1146/annurev.pathmechdis.3.121806.151409] [Cited by in Crossref: 338] [Cited by in F6Publishing: 311] [Article Influence: 24.1] [Reference Citation Analysis]
267 Kwon Y. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome. Mol Nutr Food Res 2020;64:e1900824. [PMID: 31797565 DOI: 10.1002/mnfr.201900824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
268 Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 2010;68:280-289. [PMID: 20500789 DOI: 10.1111/j.1753-4887.2010.00287.x] [Cited by in Crossref: 637] [Cited by in F6Publishing: 538] [Article Influence: 53.1] [Reference Citation Analysis]
269 Fernández-real J, Vendrell J, Ricart W. Circulating Adiponectin and Plasma Fatty Acid Profile. Clinical Chemistry 2005;51:603-9. [DOI: 10.1373/clinchem.2004.041350] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
270 Mokkala K, Houttu N, Cansev T, Laitinen K. Interactions of dietary fat with the gut microbiota: Evaluation of mechanisms and metabolic consequences. Clinical Nutrition 2020;39:994-1018. [DOI: 10.1016/j.clnu.2019.05.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
271 Peter S, Jacob JJ. Role of Omega-3 Fatty Acids in Cardiovascular Disorders. In: Hegde MV, Zanwar AA, Adekar SP, editors. Omega-3 Fatty Acids. Cham: Springer International Publishing; 2016. pp. 513-30. [DOI: 10.1007/978-3-319-40458-5_37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
272 Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep 2015;3:e12628. [PMID: 26660549 DOI: 10.14814/phy2.12628] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
273 Norris PC, Serhan CN. Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues. Biochem Biophys Res Commun 2018;504:553-61. [PMID: 29524409 DOI: 10.1016/j.bbrc.2018.03.037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
274 Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation 2012;35:98-113. [PMID: 21286796 DOI: 10.1007/s10753-011-9294-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
275 Mach N, Gao Y, Lemonnier G, Lecardonnel J, Oswald IP, Estellé J, Rogel-Gaillard C. The peripheral blood transcriptome reflects variations in immunity traits in swine: towards the identification of biomarkers. BMC Genomics 2013;14:894. [PMID: 24341289 DOI: 10.1186/1471-2164-14-894] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
276 Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun Y, Uddin J, Petasis NA, Serhan CN. Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions. Journal of Biological Chemistry 2006;281:22847-54. [DOI: 10.1074/jbc.m603766200] [Cited by in Crossref: 103] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
277 Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008;22:383-390. [PMID: 17884974 DOI: 10.1096/fj.07-8506com] [Cited by in Crossref: 292] [Cited by in F6Publishing: 230] [Article Influence: 19.5] [Reference Citation Analysis]
278 Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan SP. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 2007;21:3162-3170. [PMID: 17496159 DOI: 10.1096/fj.07-8473com] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
279 Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010;177:1576-91. [PMID: 20813960 DOI: 10.2353/ajpath.2010.100322] [Cited by in Crossref: 289] [Cited by in F6Publishing: 266] [Article Influence: 24.1] [Reference Citation Analysis]
280 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
281 Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol 2009;158:947-59. [PMID: 19785661 DOI: 10.1111/j.1476-5381.2009.00386.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 136] [Article Influence: 11.5] [Reference Citation Analysis]
282 Keim SA, Gracious B, Boone KM, Klebanoff MA, Rogers LK, Rausch J, Coury DL, Sheppard KW, Husk J, Rhoda DA. ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers. J Nutr 2018;148:227-35. [PMID: 29490101 DOI: 10.1093/jn/nxx047] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
283 Mimatsu K, Fukino N, Ogasawara Y, Saino Y, Oida T. Effects of Enteral Immunonutrition in Esophageal Cancer. Gastrointest Tumors 2018;4:61-71. [PMID: 29594107 DOI: 10.1159/000481797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
284 Ortuño Sahagún D, Márquez-Aguirre AL, Quintero-Fabián S, López-Roa RI, Rojas-Mayorquín AE. Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. PPAR Res 2012;2012:318613. [PMID: 23251142 DOI: 10.1155/2012/318613] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
285 Lima-Garcia JF, Dutra RC, da Silva K, Motta EM, Campos MM, Calixto JB. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 2011;164:278-93. [PMID: 21418187 DOI: 10.1111/j.1476-5381.2011.01345.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 13.4] [Reference Citation Analysis]
286 Baranowski M, Enns J, Blewett H, Yakandawala U, Zahradka P, Taylor CG. Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats. Cytokine 2012;59:382-91. [DOI: 10.1016/j.cyto.2012.04.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
287 Serhan CN. Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases? Expert Opinion on Therapeutic Targets 2005;8:643-52. [DOI: 10.1517/14728222.8.6.643] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
288 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
289 Yang R, Chiang N, Oh SF, Serhan CN. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr Protoc Immunol 2011;Chapter 14:Unit 14.26. [PMID: 22048801 DOI: 10.1002/0471142735.im1426s95] [Cited by in Crossref: 58] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
290 Calder PC. The role of marine omega-3 ( n -3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 2012;56:1073-80. [DOI: 10.1002/mnfr.201100710] [Cited by in Crossref: 180] [Cited by in F6Publishing: 155] [Article Influence: 18.0] [Reference Citation Analysis]
291 Hachem M. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators. Biochimie 2021;184:95-103. [PMID: 33639198 DOI: 10.1016/j.biochi.2021.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Krishnamurthy VR, Dougherty A, Haller CA, Chaikof EL. Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid. J Org Chem 2011;76:5433-7. [PMID: 21598971 DOI: 10.1021/jo2002243] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
293 Jónasdóttir HS, Brouwers H, Kwekkeboom JC, van der Linden HMJ, Huizinga T, Kloppenburg M, Toes REM, Giera M, Ioan-Facsinay A. Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans. Osteoarthritis Cartilage 2017;25:1150-60. [PMID: 28189826 DOI: 10.1016/j.joca.2017.01.018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
294 Baker LA, Martin NRW, Kimber MC, Pritchard GJ, Lindley MR, Lewis MP. Resolvin E1 (R v E 1 ) attenuates LPS induced inflammation and subsequent atrophy in C2C12 myotubes. J Cell Biochem 2018;119:6094-103. [DOI: 10.1002/jcb.26807] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
295 Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci 2020;3:88-106. [PMID: 32259091 DOI: 10.1021/acsptsci.9b00075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
296 Markworth JF, Kaur G, Miller EG, Larsen AE, Sinclair AJ, Maddipati KR, Cameron-Smith D. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid. FASEB J 2016;30:3714-25. [PMID: 27461565 DOI: 10.1096/fj.201600360R] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 9.2] [Reference Citation Analysis]
297 Kotlyarov S, Kotlyarova A. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:12803. [PMID: 34884621 DOI: 10.3390/ijms222312803] [Reference Citation Analysis]
298 Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40:315-327. [PMID: 24656045 DOI: 10.1016/j.immuni.2014.02.009] [Cited by in Crossref: 436] [Cited by in F6Publishing: 429] [Article Influence: 54.5] [Reference Citation Analysis]
299 Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, Yan S, Shen Y, Guo S, Zhu M, Yin H, Funk CD, Zhang J, Yu Y. Resolvin E1 attenuates inj ury‐induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. FASEB j 2018;32:5413-25. [DOI: 10.1096/fj.201800173r] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
300 Calder PC. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie. 2009;91:791-795. [PMID: 19455748 DOI: 10.1016/j.biochi.2009.01.008] [Cited by in Crossref: 448] [Cited by in F6Publishing: 391] [Article Influence: 34.5] [Reference Citation Analysis]
301 Calder PC, Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009;121:148-57. [PMID: 19940425 DOI: 10.3810/pgm.2009.11.2083] [Cited by in Crossref: 136] [Cited by in F6Publishing: 118] [Article Influence: 11.3] [Reference Citation Analysis]
302 Geisler AC, Rudolph TK. Nitroalkylation--a redox sensitive signaling pathway. Biochim Biophys Acta 2012;1820:777-84. [PMID: 21723375 DOI: 10.1016/j.bbagen.2011.06.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
303 Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol 2014;307:C39-54. [PMID: 24696140 DOI: 10.1152/ajpcell.00024.2014] [Cited by in Crossref: 276] [Cited by in F6Publishing: 268] [Article Influence: 34.5] [Reference Citation Analysis]
304 Ma Q, Shen JH, Shen SR, Das UN. Bioactive lipids in pathological retinopathy. Crit Rev Food Sci Nutr 2014;54:1-16. [PMID: 24188230 DOI: 10.1080/10408398.2011.565523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
305 Serhan CN. Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution. Scandinavian Journal of Food and Nutrition 2016;50:68-78. [DOI: 10.1080/17482970601066298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
306 Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Current Opinion in Clinical Nutrition & Metabolic Care 2006;9:140-8. [DOI: 10.1097/01.mco.0000214573.75062.0a] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
307 Haas-Stapleton EJ, Lu Y, Hong S, Arita M, Favoreto S, Nigam S, Serhan CN, Agabian N. Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS One 2007;2:e1316. [PMID: 18091990 DOI: 10.1371/journal.pone.0001316] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
308 Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep 2017;19:57. [PMID: 29110146 DOI: 10.1007/s11883-017-0696-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
309 Yanai R, Mulki L, Hasegawa E, Takeuchi K, Sweigard H, Suzuki J, Gaissert P, Vavvas DG, Sonoda KH, Rothe M, Schunck WH, Miller JW, Connor KM. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization. Proc Natl Acad Sci U S A 2014;111:9603-8. [PMID: 24979774 DOI: 10.1073/pnas.1401191111] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
310 Sato M, Aoki-Saito H, Fukuda H, Ikeda H, Koga Y, Yatomi M, Tsurumaki H, Maeno T, Saito T, Nakakura T, Mori T, Yanagawa M, Abe M, Sako Y, Dobashi K, Ishizuka T, Yamada M, Shuto S, Hisada T. Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway. FASEB J 2019;33:12750-9. [PMID: 31469599 DOI: 10.1096/fj.201900283R] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
311 Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci Signal 2018;11:eaar3721. [PMID: 30254055 DOI: 10.1126/scisignal.aar3721] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
312 El Kebir D, Filep JG. Modulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins. Front Immunol 2013;4:60. [PMID: 23508943 DOI: 10.3389/fimmu.2013.00060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
313 Mazidimoradi A, Alemzadeh E, Alemzadeh E, Salehiniya H. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review. Life Sci 2022;:120489. [PMID: 35358595 DOI: 10.1016/j.lfs.2022.120489] [Reference Citation Analysis]
314 Serhan CN, Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest. 2001;107:1481-1489. [PMID: 11413151 DOI: 10.1172/jci13375] [Cited by in Crossref: 108] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
315 Ambaw YA, Wong T, Chong R, Ah H, Ji S, Raida M, Torta F, Wenk MR, Tong L. Change of tear lipid mediators in a post-trabeculectomy cohort. Ocul Surf 2020;18:565-74. [PMID: 32622916 DOI: 10.1016/j.jtos.2020.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
316 Krishnamoorthy N, Abdulnour RE, Walker KH, Engstrom BD, Levy BD. Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases. Physiol Rev 2018;98:1335-70. [PMID: 29717929 DOI: 10.1152/physrev.00026.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
317 Barden A, Shinde S, Tsai I, Croft K, Beilin L, Puddey I, Mori T. Effect of weight loss on neutrophil resolvins in the metabolic syndrome. Prostaglandins, Leukotrienes and Essential Fatty Acids 2019;148:25-9. [DOI: 10.1016/j.plefa.2019.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
318 Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 2009;50:4743-52. [PMID: 19407006 DOI: 10.1167/iovs.08-2462] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 7.5] [Reference Citation Analysis]
319 Zhang F, Yang H, Pan Z, Wang Z, Wolosin JM, Gjorstrup P, Reinach PS. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci 2010;51:5601-9. [PMID: 20538990 DOI: 10.1167/iovs.09-4468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
320 Sekheri M, El Kebir D, Edner N, Filep JG. 15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc Natl Acad Sci U S A 2020;117:7971-80. [PMID: 32205444 DOI: 10.1073/pnas.1920193117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
321 Lee JY, Han SH, Park MH, Song IS, Choi MK, Yu E, Park CM, Kim HJ, Kim SH, Schuchman EH, Jin HK, Bae JS. N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease. Nat Commun 2020;11:2358. [PMID: 32398649 DOI: 10.1038/s41467-020-16080-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
322 Kumar A, Behl T, Jamwal S, Kaur I, Sood A, Kumar P. Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder. Mol Biol Rep 2020;47:9895-912. [PMID: 33263931 DOI: 10.1007/s11033-020-06033-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Vara-messler M, Buccellati C, Pustina L, Folco G, Rovati GE, Hoxha M. A potential role of PUFAs and COXIBs in cancer chemoprevention. Prostaglandins & Other Lipid Mediators 2015;120:97-102. [DOI: 10.1016/j.prostaglandins.2015.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
324 Das UN. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 2013;88:201-10. [PMID: 23295193 DOI: 10.1016/j.plefa.2012.11.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
325 Doggrell SA. Resolvin inflammation with pain. Expert Opin Investig Drugs 2010;19:1461-4. [PMID: 20942774 DOI: 10.1517/13543784.2010.527946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
326 Plourde M, Chouinard-Watkins R, Rioux-Perreault C, Fortier M, Dang MT, Allard MJ, Tremblay-Mercier J, Zhang Y, Lawrence P, Vohl MC, Perron P, Lorrain D, Brenna JT, Cunnane SC. Kinetics of 13C-DHA before and during fish-oil supplementation in healthy older individuals. Am J Clin Nutr 2014;100:105-12. [PMID: 24829492 DOI: 10.3945/ajcn.113.074708] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
327 Calder PC. n-3 fatty acids, inflammation, and immunity--relevance to postsurgical and critically ill patients. Lipids 2004;39:1147-61. [PMID: 15736910 DOI: 10.1007/s11745-004-1342-z] [Cited by in Crossref: 114] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
328 Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005;15:159-66. [PMID: 15912889 DOI: 10.1111/j.1750-3639.2005.tb00513.x] [Cited by in Crossref: 218] [Cited by in F6Publishing: 188] [Article Influence: 12.8] [Reference Citation Analysis]
329 Stopka-farooqui U, Haworth O. Proresolving mediators: new therapies to treat inflammatory diseases. Clinical Lipidology 2015;10:343-50. [DOI: 10.2217/clp.15.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
330 Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases 2016; 4(7): 155-164 [PMID: 27458590 DOI: 10.12998/wjcc.v4.i7.155] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
331 Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, Birnbaum Y. Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2010;299:H153-64. [PMID: 20435846 DOI: 10.1152/ajpheart.01057.2009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 9.1] [Reference Citation Analysis]
332 Lee JE, Sun Y, Gjorstrup P, Pearlman E. Inhibition of Corneal Inflammation by the Resolvin E1. Invest Ophthalmol Vis Sci 2015;56:2728-36. [PMID: 25758817 DOI: 10.1167/iovs.14-15982] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
333 Kutzner L, Rund KM, Ostermann AI, Hartung NM, Galano JM, Balas L, Durand T, Balzer MS, David S, Schebb NH. Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples. Front Pharmacol 2019;10:169. [PMID: 30899221 DOI: 10.3389/fphar.2019.00169] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
334 Rodríguez M, G Rebollar P, Mattioli S, Castellini C. n-3 PUFA Sources (Precursor/Products): A Review of Current Knowledge on Rabbit. Animals (Basel) 2019;9:E806. [PMID: 31618904 DOI: 10.3390/ani9100806] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
335 Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 2016;73:3861-85. [PMID: 27180275 DOI: 10.1007/s00018-016-2268-0] [Cited by in Crossref: 397] [Cited by in F6Publishing: 344] [Article Influence: 66.2] [Reference Citation Analysis]
336 Loew A, Köhnke T, Rehbeil E, Pietzner A, Weylandt KH. A Role for Lipid Mediators in Acute Myeloid Leukemia. Int J Mol Sci 2019;20:E2425. [PMID: 31100828 DOI: 10.3390/ijms20102425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
337 Shi J, Zhang X, Jiang L, Zhang L, Dong Y, Midgley AC, Kong D, Wang S. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration. Acta Biomaterialia 2019;97:360-73. [DOI: 10.1016/j.actbio.2019.07.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
338 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
339 de la Rosa X, Norris PC, Chiang N, Rodriguez AR, Spur BW, Serhan CN. Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration. Am J Pathol 2018;188:950-66. [PMID: 29571326 DOI: 10.1016/j.ajpath.2018.01.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
340 Nye M, Rudner S, Bielory L. Emerging therapies in allergic conjunctivitis and dry eye syndrome. Expert Opinion on Pharmacotherapy 2013;14:1449-65. [DOI: 10.1517/14656566.2013.802773] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
341 Jordan KD, Upmacis RK. Mass spectrometric analysis of oxidized eicosapentaenoic Acid sodium salt. Lipid Insights 2013;6:21-35. [PMID: 25278766 DOI: 10.4137/LPI.S10862] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
342 Das UN. Albumin to globulin ratio and/or plasma albumin in predicting long-term mortality. Am J Surg 2014;208:157-8. [PMID: 24524861 DOI: 10.1016/j.amjsurg.2013.08.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
343 Cordaro M, Cuzzocrea S, Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9:E216. [PMID: 32150935 DOI: 10.3390/antiox9030216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
344 Ross JA, Fearon KC. Eicosanoid-dependent cancer cachexia and wasting. Curr Opin Clin Nutr Metab Care 2002;5:241-8. [PMID: 11953648 DOI: 10.1097/00075197-200205000-00002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
345 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
346 Flower RJ, Perretti M. Controlling inflammation: a fat chance? J Exp Med 2005;201:671-4. [PMID: 15753201 DOI: 10.1084/jem.20050222] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
347 Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A 2004;101:15178-83. [PMID: 15471991 DOI: 10.1073/pnas.0405445101] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 9.7] [Reference Citation Analysis]
348 Ferrer MD, Busquets-Cortés C, Capó X, Tejada S, Tur JA, Pons A, Sureda A. Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases. Curr Med Chem 2019;26:3225-41. [PMID: 29756563 DOI: 10.2174/0929867325666180514112124] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
349 Okamura T, Hashimoto Y, Miki A, Kaji A, Sakai R, Iwai K, Osaka T, Ushigome E, Hamaguchi M, Yamazaki M, Fukui M. Reduced dietary omega-3 fatty acids intake is associated with sarcopenia in elderly patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study. J Clin Biochem Nutr 2020;66:233-7. [PMID: 32523250 DOI: 10.3164/jcbn.19-85] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
350 Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 2012;180:2018-27. [PMID: 22449948 DOI: 10.1016/j.ajpath.2012.01.028] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 16.4] [Reference Citation Analysis]
351 Scarparo RK, Dondoni L, Böttcher DE, Grecca FS, Figueiredo JAP, Kantarci A, Van Dyke TE, Batista EL. Intracanal Delivery of Resolvin E1 Controls Inflammation in Necrotic Immature Rat Teeth. Journal of Endodontics 2014;40:678-82. [DOI: 10.1016/j.joen.2013.12.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
352 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Reference Citation Analysis]
353 Thai JD, Gregory KE. Bioactive Factors in Human Breast Milk Attenuate Intestinal Inflammation during Early Life. Nutrients 2020;12:E581. [PMID: 32102231 DOI: 10.3390/nu12020581] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
354 Saika A, Nagatake T, Hirata SI, Sawane K, Adachi J, Abe Y, Isoyama J, Morimoto S, Node E, Tiwari P, Hosomi K, Matsunaga A, Honda T, Tomonaga T, Arita M, Kabashima K, Kunisawa J. ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α. FASEB J 2021;35:e21354. [PMID: 33749892 DOI: 10.1096/fj.202001687R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Musso G, Gambino R, Cassader M, Paschetta E, Sircana A. Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. Trends in Pharmacological Sciences 2018;39:387-401. [DOI: 10.1016/j.tips.2018.01.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
356 Bazan NG. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 2005;32:89-103. [PMID: 16077186 DOI: 10.1385/MN:32:1:089] [Cited by in Crossref: 157] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
357 Hecker M, Ott J, Sondermann C, Schaefer M, Obert M, Hecker A, Morty RE, Vadasz I, Herold S, Rosengarten B, Witzenrath M, Seeger W, Mayer K. Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome. Crit Care 2014;18:R85. [PMID: 24780004 DOI: 10.1186/cc13850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
358 Poulsen RC, Gotlinger KH, Serhan CN, Kruger MC. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am J Hematol 2008;83:437-45. [PMID: 18429055 DOI: 10.1002/ajh.21170] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
359 Owens CD, Gasper WJ, Rahman AS, Conte MS. Vein graft failure. J Vasc Surg 2015;61:203-16. [PMID: 24095042 DOI: 10.1016/j.jvs.2013.08.019] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
360 Liu M, Chen P, Véricel E, Lelli M, Béguin L, Lagarde M, Guichardant M. Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA. J Lipid Res 2013;54:2083-94. [PMID: 23740966 DOI: 10.1194/jlr.M035139] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
361 Saika A, Nagatake T, Kishino S, Park SB, Honda T, Matsumoto N, Shimojou M, Morimoto S, Tiwari P, Node E, Hirata SI, Hosomi K, Kabashima K, Ogawa J, Kunisawa J. 17(S),18(R)-epoxyeicosatetraenoic acid generated by cytochrome P450 BM-3 from Bacillus megaterium inhibits the development of contact hypersensitivity via G-protein-coupled receptor 40-mediated neutrophil suppression. FASEB Bioadv 2020;2:59-71. [PMID: 32123857 DOI: 10.1096/fba.2019-00061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
362 Freire MO, Dalli J, Serhan CN, Van Dyke TE. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. J Immunol 2017;198:718-28. [PMID: 27994073 DOI: 10.4049/jimmunol.1601543] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
363 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
364 Seki H, Tani Y, Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 2009;89:126-130. [PMID: 19737659 DOI: 10.1016/j.prostaglandins.2009.03.002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
365 Cas MD, Roda G, Li F, Secundo F. Functional Lipids in Autoimmune Inflammatory Diseases. Int J Mol Sci 2020;21:E3074. [PMID: 32349258 DOI: 10.3390/ijms21093074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
366 Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. The Journal of Nutritional Biochemistry 2010;21:781-92. [DOI: 10.1016/j.jnutbio.2009.12.004] [Cited by in Crossref: 326] [Cited by in F6Publishing: 276] [Article Influence: 27.2] [Reference Citation Analysis]
367 Flock MR, Rogers CJ, Prabhu KS, Kris-Etherton PM. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Res Rev 2013;29:431-45. [PMID: 23592441 DOI: 10.1002/dmrr.2414] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
368 Isobe Y, Arita M, Iwamoto R, Urabe D, Todoroki H, Masuda K, Inoue M, Arai H. Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3. J Biochem 2013;153:355-60. [PMID: 23293324 DOI: 10.1093/jb/mvs151] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
369 Libreros S, Shay AE, Nshimiyimana R, Fichtner D, Martin MJ, Wourms N, Serhan CN. A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution. Front Immunol 2020;11:631319. [PMID: 33643307 DOI: 10.3389/fimmu.2020.631319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
370 Hasan RA, OʼBrien E, Mancuso P. Lipoxin A(4) and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatr Crit Care Med 2012;13:141-5. [PMID: 21666533 DOI: 10.1097/PCC.0b013e3182231644] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
371 Wheatley C. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses 2006;67:124-42. [PMID: 16545917 DOI: 10.1016/j.mehy.2006.01.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
372 González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J, Clària J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 2006;20:2537-9. [PMID: 17056761 DOI: 10.1096/fj.06-6250fje] [Cited by in Crossref: 151] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis]
373 Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176-183. [PMID: 17337246 DOI: 10.1016/j.it.2007.02.007] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 16.1] [Reference Citation Analysis]
374 Kalinec GM, Lomberk G, Urrutia RA, Kalinec F. Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss. Front Cell Neurosci 2017;11:192. [PMID: 28736517 DOI: 10.3389/fncel.2017.00192] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 10.4] [Reference Citation Analysis]
375 Collodel G, Moretti E, Noto D, Iacoponi F, Signorini C. Fatty Acid Profile and Metabolism Are Related to Human Sperm Parameters and Are Relevant in Idiopathic Infertility and Varicocele. Mediators Inflamm 2020;2020:3640450. [PMID: 32934603 DOI: 10.1155/2020/3640450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
376 Radbakhsh S, Katsiki N, Santos RD, Mikhailidis DP, Mantzoros CS, Sahebkar A. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation. Metabolism 2022;:155211. [PMID: 35533891 DOI: 10.1016/j.metabol.2022.155211] [Reference Citation Analysis]
377 Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 2011;186:4455-66. [PMID: 21357260 DOI: 10.4049/jimmunol.1000833] [Cited by in Crossref: 74] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
378 Filep JG, Ariel A. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation. Am J Physiol Cell Physiol 2020;319:C510-32. [PMID: 32667864 DOI: 10.1152/ajpcell.00181.2020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
379 Gong Y, Lin M, Piao L, Li X, Yang F, Zhang J, Xiao B, Zhang Q, Song WL, Yin H, Zhu L, Funk CD, Yu Y. Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling. Br J Pharmacol 2015;172:5647-60. [PMID: 25339093 DOI: 10.1111/bph.12986] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
380 Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases. Clinical Immunology 2006;119:229-40. [DOI: 10.1016/j.clim.2006.01.016] [Cited by in Crossref: 400] [Cited by in F6Publishing: 385] [Article Influence: 25.0] [Reference Citation Analysis]
381 Devitt A, Griffiths HR, Milic I. Communicating with the dead: lipids, lipid mediators and extracellular vesicles. Biochem Soc Trans 2018;46:631-9. [PMID: 29743274 DOI: 10.1042/BST20160477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
382 Cholkar K, Gilger BC, Mitra AK. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045). Int J Pharm 2016;498:326-34. [PMID: 26706439 DOI: 10.1016/j.ijpharm.2015.12.037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
383 Callahan BP, Ciulla DA, Wagner AG, Xu Z, Zhang X. Specificity Distorted: Chemical Induction of Biological Paracatalysis. Biochemistry 2020;59:3517-22. [PMID: 32931253 DOI: 10.1021/acs.biochem.0c00643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Ma X, Jiang Z, Lai C. Significance of Increasing n-3 PUFA Content in Pork on Human Health. Crit Rev Food Sci Nutr 2016;56:858-70. [PMID: 26237277 DOI: 10.1080/10408398.2013.850059] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
385 Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, Tompkins RG, Fagan SP, Irimia D. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J 2013;27:2270-81. [PMID: 23430978 DOI: 10.1096/fj.12-219519] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
386 Capra V, Bäck M, Barbieri SS, Camera M, Tremoli E, Rovati GE. Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke: EICOSANOIDS AND THEIR DRUGS IN CVDS. Med Res Rev 2013;33:364-438. [DOI: 10.1002/med.21251] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
387 Roberts LJ 2nd, Milne GL. Isoprostanes. J Lipid Res 2009;50 Suppl:S219-23. [PMID: 18957694 DOI: 10.1194/jlr.R800037-JLR200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
388 Kominsky DJ, Campbell EL, Colgan SP. Metabolic shifts in immunity and inflammation. J Immunol 2010;184:4062-8. [PMID: 20368286 DOI: 10.4049/jimmunol.0903002] [Cited by in Crossref: 216] [Cited by in F6Publishing: 204] [Article Influence: 18.0] [Reference Citation Analysis]
389 Van Dyke TE. Control of inflammation and periodontitis. Periodontol 2000. 2007;45:158-166. [PMID: 17850455 DOI: 10.1111/j.1600-0757.2007.00229.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
390 Dalli J, Serhan CN. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function. Front Immunol 2017;8:1400. [PMID: 29163481 DOI: 10.3389/fimmu.2017.01400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
391 Dalli J, Winkler JW, Colas RA, Arnardottir H, Cheng CY, Chiang N, Petasis NA, Serhan CN. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol 2013;20:188-201. [PMID: 23438748 DOI: 10.1016/j.chembiol.2012.11.010] [Cited by in Crossref: 145] [Cited by in F6Publishing: 139] [Article Influence: 16.1] [Reference Citation Analysis]
392 Bhansali RS. Non-surgical periodontal therapy: An update on current evidence. World J Stomatol 2014; 3(4): 38-51 [DOI: 10.5321/wjs.v3.i4.38] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Hellström A, Ley D, Hansen-Pupp I, Niklasson A, Smith L, Löfqvist C, Hård AL. New insights into the development of retinopathy of prematurity--importance of early weight gain. Acta Paediatr 2010;99:502-8. [PMID: 19878131 DOI: 10.1111/j.1651-2227.2009.01568.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
394 Halade GV, Tourki B. Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure. Adv Exp Med Biol 2019;1161:45-64. [PMID: 31562621 DOI: 10.1007/978-3-030-21735-8_6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
395 Calder PC. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritis: Symposium on ‘The challenge of translating nutrition research into public health nutrition’. Proc Nutr Soc 2008;67:409-18. [DOI: 10.1017/s0029665108008690] [Cited by in Crossref: 81] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
396 Ishizuka T, Hisada T, Aoki H, Mori M. Resolvin E1: a novel lipid mediator in the resolution of allergic airway inflammation. Expert Rev Clin Immunol 2008;4:669-72. [PMID: 20477116 DOI: 10.1586/1744666X.4.6.669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
397 Leoni G, Soehnlein O. (Re) Solving Repair After Myocardial Infarction. Front Pharmacol 2018;9:1342. [PMID: 30534069 DOI: 10.3389/fphar.2018.01342] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
398 González-gil EM, Santabárbara J, Siani A, Ahrens W, Sioen I, Eiben G, Günther K, Iacoviello L, Molnar D, Risé P, Russo P, Tornaritis M, Veidebaum T, Galli C, Moreno LA; on behalf of the IDEFICS Consortium. Whole-blood fatty acids and inflammation in European children: the IDEFICS Study. Eur J Clin Nutr 2016;70:819-23. [DOI: 10.1038/ejcn.2015.219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
399 Yacoubian S, Serhan CN. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3:570-579; quiz 1 p following 589. [PMID: 17906612 DOI: 10.1038/ncprheum0616] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
400 Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA. Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog 2017;56:1977-83. [PMID: 28218420 DOI: 10.1002/mc.22629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
401 Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ. Key roles for lipid mediators in the adaptive immune response. J Clin Invest 2018;128:2724-31. [PMID: 30108196 DOI: 10.1172/JCI97951] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
402 de Oliveira Otto MC, Wu JH, Baylin A, Vaidya D, Rich SS, Tsai MY, Jacobs DR Jr, Mozaffarian D. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2013;2:e000506. [PMID: 24351702 DOI: 10.1161/JAHA.113.000506] [Cited by in Crossref: 96] [Cited by in F6Publishing: 68] [Article Influence: 10.7] [Reference Citation Analysis]
403 Dalli J, Pistorius K, Walker ME. Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation. In: Honn KV, Zeldin DC, editors. The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases. Cham: Springer International Publishing; 2019. pp. 65-75. [DOI: 10.1007/978-3-030-21735-8_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
404 Knöchel C, Voss M, Grüter F, Alves GS, Matura S, Sepanski B, Stäblein M, Wenzler S, Prvulovic D, Carvalho AF, Oertel-Knöchel V. Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia? Curr Neuropharmacol 2015;13:663-80. [PMID: 26467414 DOI: 10.2174/1570159x13666150630173047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
405 El Kholy K, Freire M, Chen T, Van Dyke TE. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. Front Immunol 2018;9:1300. [PMID: 29946319 DOI: 10.3389/fimmu.2018.01300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
406 Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta 2010;1801:1260-73. [PMID: 20708099 DOI: 10.1016/j.bbalip.2010.08.002] [Cited by in Crossref: 253] [Cited by in F6Publishing: 240] [Article Influence: 21.1] [Reference Citation Analysis]
407 Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, Viappiani S, Librizzi L, Hernandez A, Murphy RC, Constantin G, De Curtis M, Folco G, Sala A. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 2004;18:842-4. [PMID: 15001558 DOI: 10.1096/fj.03-0599fje] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
408 Sudheendran S, Chang CC, Deckelbaum RJ. N-3 vs. saturated fatty acids: effects on the arterial wall. Prostaglandins Leukot Essent Fatty Acids 2010;82:205-9. [PMID: 20207121 DOI: 10.1016/j.plefa.2010.02.020] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
409 Luerman GC, Uriarte SM, Rane MJ, McLeish KR. Application of proteomics to neutrophil biology. J Proteomics 2010;73:552-61. [PMID: 19580889 DOI: 10.1016/j.jprot.2009.06.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
410 Soory M. Oxidative stress induced mechanisms in the progression of periodontal diseases and cancer: a common approach to redox homeostasis? Cancers (Basel) 2010;2:670-92. [PMID: 24281088 DOI: 10.3390/cancers2020670] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
411 Das UN. Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. Nutrition 2011;27:21-5. [DOI: 10.1016/j.nut.2010.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
412 Anderson P, Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol Med 2008;12:1830-47. [PMID: 18554314 DOI: 10.1111/j.1582-4934.2008.00387.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
413 Funaki Y, Hasegawa Y, Okazaki R, Yamasaki A, Sueda Y, Yamamoto A, Yanai M, Fukushima T, Harada T, Makino H, Shimizu E. Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast Differentiation. Yonago Acta Med 2018;61:8-18. [PMID: 29599617 [PMID: 29599617 DOI: 10.33160/yam.2018.03.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
414 Dobson EP, Barrow CJ, Adcock JL. Solvent-induced 7R-dioxygenase activity of soybean 15-lipoxygenase-1 in the formation of omega-3 DPA-derived resolvin analogs. Journal of Molecular Catalysis B: Enzymatic 2014;108:96-102. [DOI: 10.1016/j.molcatb.2014.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
415 Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 2010;285:3451-61. [PMID: 19906641 DOI: 10.1074/jbc.M109.044131] [Cited by in Crossref: 170] [Cited by in F6Publishing: 109] [Article Influence: 13.1] [Reference Citation Analysis]
416 Tungen JE, Aursnes M, Hansen TV. Stereoselective synthesis of maresin 1. Tetrahedron Letters 2015;56:1843-6. [DOI: 10.1016/j.tetlet.2015.02.080] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
417 Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med. 2009;206:15-23. [PMID: 19103881 DOI: 10.1084/jem.20081880] [Cited by in Crossref: 541] [Cited by in F6Publishing: 506] [Article Influence: 38.6] [Reference Citation Analysis]
418 Mckiel LA, Woodhouse KA, Fitzpatrick LE. The role of Toll-like receptor signaling in the macrophage response to implanted materials. MRS Communications 2020;10:55-68. [DOI: 10.1557/mrc.2019.154] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
419 Bazan NG. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Mol Aspects Med 2018;64:18-33. [PMID: 30244005 DOI: 10.1016/j.mam.2018.09.003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 15.5] [Reference Citation Analysis]
420 Chatterjee A, Komshian S, Sansbury BE, Wu B, Mottola G, Chen M, Spite M, Conte MS. Biosynthesis of proresolving lipid mediators by vascular cells and tissues. FASEB J 2017;31:3393-402. [PMID: 28442547 DOI: 10.1096/fj.201700082R] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
421 Sansbury BE, Spite M. Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. Circ Res 2016;119:113-30. [PMID: 27340271 DOI: 10.1161/CIRCRESAHA.116.307308] [Cited by in Crossref: 91] [Cited by in F6Publishing: 48] [Article Influence: 18.2] [Reference Citation Analysis]
422 Kelavkar UP, Hutzley J, McHugh K, Allen KG, Parwani A. Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes. Neoplasia 2009;11:692-9. [PMID: 19568414 DOI: 10.1593/neo.09334] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
423 Borges FT, Convento MB, Schor N. Bone marrow-derived mesenchymal stromal cell: What next? Stem Cells Cloning. 2018;11:77-83. [PMID: 30510433 DOI: 10.2147/sccaa.s147804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
424 Zhu M, Wang X, Hjorth E, Colas RA, Schroeder L, Granholm AC, Serhan CN, Schultzberg M. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol 2016;53:2733-49. [PMID: 26650044 DOI: 10.1007/s12035-015-9544-0] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 12.4] [Reference Citation Analysis]
425 Clària J, Nguyen BT, Madenci AL, Ozaki CK, Serhan CN. Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol 2013;304:C1141-9. [PMID: 23364264 DOI: 10.1152/ajpcell.00351.2012] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
426 Fiaccavento R, Carotenuto F, Minieri M, Masuelli L, Vecchini A, Bei R, Modesti A, Binaglia L, Fusco A, Bertoli A, Forte G, Carosella L, Di Nardo P. Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters. Am J Pathol 2006;169:1913-24. [PMID: 17148657 DOI: 10.2353/ajpath.2006.051320] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
427 Serhan CN, Chiang N. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics. Rheumatic Disease Clinics of North America 2004;30:69-95. [DOI: 10.1016/s0889-857x(03)00117-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
428 Colgan SP, Curtis VF, Campbell EL. The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis. 2013;19:2238-2244. [PMID: 23702808 DOI: 10.1097/mib.0b013e31828dcaaf] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
429 Gilroy DW, Bishop-Bailey D. Lipid mediators in immune regulation and resolution. Br J Pharmacol 2019;176:1009-23. [PMID: 30674066 DOI: 10.1111/bph.14587] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
430 Maroufyan E, Kasim A, Ebrahimi M, Loh T, Hair-bejo M, Soleimani A. Dietary methionine and n-6/n-3 polyunsaturated fatty acid ratio reduce adverse effects of infectious bursal disease in broilers. Poultry Science 2012;91:2173-82. [DOI: 10.3382/ps.2012-02317] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
431 Vasconcelos DP, Costa M, Amaral IF, Barbosa MA, Águas AP, Barbosa JN. Development of an immunomodulatory biomaterial: Using resolvin D1 to modulate inflammation. Biomaterials 2015;53:566-73. [DOI: 10.1016/j.biomaterials.2015.02.120] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 7.6] [Reference Citation Analysis]
432 Almeida L, Everts B. Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells. Eur J Immunol 2021;51:1628-40. [PMID: 33788250 DOI: 10.1002/eji.202048944] [Reference Citation Analysis]
433 Dalli J, Colas RA, Serhan CN. Novel n-3 immunoresolvents: structures and actions. Sci Rep 2013;3:1940. [PMID: 23736886 DOI: 10.1038/srep01940] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 16.0] [Reference Citation Analysis]
434 Markworth JF, Sugg KB, Sarver DC, Maddipati KR, Brooks SV. Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse. FASEB J 2021;35:e21655. [PMID: 34042218 DOI: 10.1096/fj.202100078R] [Reference Citation Analysis]
435 Maskrey BH, Megson IL, Rossi AG, Whitfield PD. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis. Mol Nutr Food Res 2013;57:1390-400. [PMID: 23417926 DOI: 10.1002/mnfr.201200723] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
436 Chen CT, Bazinet RP. β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins, Leukotrienes and Essential Fatty Acids 2015;92:33-40. [DOI: 10.1016/j.plefa.2014.05.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 8.6] [Reference Citation Analysis]
437 Heath RJ, Wood TR. Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue. Int J Mol Sci 2021;22:11826. [PMID: 34769257 DOI: 10.3390/ijms222111826] [Reference Citation Analysis]
438 Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019;176:1024-37. [PMID: 29679485 DOI: 10.1111/bph.14336] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
439 Dondoni L, Scarparo RK, Kantarci A, Van Dyke TE, Figueiredo JA, Batista EL Jr. Effect of the pro-resolution lipid mediator Resolvin E1 (RvE1) on pulp tissues exposed to the oral environment. Int Endod J 2014;47:827-34. [PMID: 24298979 DOI: 10.1111/iej.12224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
440 Das UN. Inflammation. Molecular Basis of Health and Disease. Dordrecht: Springer Netherlands; 2011. pp. 15-100. [DOI: 10.1007/978-94-007-0495-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
441 Serhan CN. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins: . Current Opinion in Clinical Nutrition and Metabolic Care 2005;8:115-21. [DOI: 10.1097/00075197-200503000-00003] [Cited by in Crossref: 166] [Cited by in F6Publishing: 129] [Article Influence: 9.8] [Reference Citation Analysis]
442 Morris G, Berk M, Walder K, O'Neil A, Maes M, Puri BK. The lipid paradox in neuroprogressive disorders: Causes and consequences. Neurosci Biobehav Rev 2021;128:35-57. [PMID: 34118292 DOI: 10.1016/j.neubiorev.2021.06.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Lee SA, Kim HJ, Chang KC, Baek JC, Park JK, Shin JK, Choi WJ, Lee JH, Paik WY. DHA and EPA Down-regulate COX-2 Expression through Suppression of NF-kappaB Activity in LPS-treated Human Umbilical Vein Endothelial Cells. Korean J Physiol Pharmacol 2009;13:301-7. [PMID: 19885014 DOI: 10.4196/kjpp.2009.13.4.301] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
444 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Reference Citation Analysis]
445 Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003;278:14677-14687. [PMID: 12590139 DOI: 10.1074/jbc.m300218200] [Cited by in Crossref: 711] [Cited by in F6Publishing: 314] [Article Influence: 37.4] [Reference Citation Analysis]
446 Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 2003;44:2221-33. [PMID: 13130128 DOI: 10.1194/jlr.R300013-JLR200] [Cited by in Crossref: 185] [Cited by in F6Publishing: 76] [Article Influence: 9.7] [Reference Citation Analysis]
447 Levy BD, Vachier I, Serhan CN. Resolution of inflammation in asthma. Clin Chest Med 2012;33:559-70. [PMID: 22929102 DOI: 10.1016/j.ccm.2012.06.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
448 Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol 2011;186:1735-46. [PMID: 21187448 DOI: 10.4049/jimmunol.1003456] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
449 Spite M. Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease. Proc Nutr Soc 2013;72:441-50. [PMID: 23991833 DOI: 10.1017/S0029665113003030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
450 Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, Hug C, Pilet M, Roulet M. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr. 2006;25:418-427. [PMID: 16325968 DOI: 10.1016/j.clnu.2005.10.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
451 Thorp EB, Boada C, Jarbath C, Luo X. Nanoparticle Platforms for Antigen-Specific Immune Tolerance. Front Immunol 2020;11:945. [PMID: 32508829 DOI: 10.3389/fimmu.2020.00945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
452 Dalli J, Kraft BD, Colas RA, Shinohara M, Fredenburgh LE, Hess DR, Chiang N, Welty-Wolf K, Choi AM, Piantadosi CA, Serhan CN. The Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide. Am J Respir Cell Mol Biol 2015;53:314-25. [PMID: 25568926 DOI: 10.1165/rcmb.2014-0299OC] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 5.9] [Reference Citation Analysis]
453 Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases. Clin Rev Allergy Immunol 2020;58:82-91. [PMID: 31267470 DOI: 10.1007/s12016-019-08754-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
454 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
455 Zhang Y, Igwe OJ. Role of Toll-like receptor 4/oxidant-coupled activation in regulating the biosynthesis of omega-3 polyunsaturated fatty acid derivative resolvin D1 in primary murine peritoneal macrophage. Biochem Pharmacol 2018;158:73-83. [PMID: 30287282 DOI: 10.1016/j.bcp.2018.09.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
456 Headland SE, Norling LV. The resolution of inflammation: Principles and challenges. Semin Immunol 2015;27:149-60. [PMID: 25911383 DOI: 10.1016/j.smim.2015.03.014] [Cited by in Crossref: 191] [Cited by in F6Publishing: 175] [Article Influence: 27.3] [Reference Citation Analysis]
457 Serhan CN, Arita M, Hong S, Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004;39:1125-32. [PMID: 15726828 DOI: 10.1007/s11745-004-1339-7] [Cited by in Crossref: 233] [Cited by in F6Publishing: 200] [Article Influence: 13.7] [Reference Citation Analysis]
458 Kraft JD, Blomgran R, Lundgaard I, Quiding-Järbrink M, Bromberg JS, Börgeson E. Specialized Pro-Resolving Mediators and the Lymphatic System. Int J Mol Sci 2021;22:2750. [PMID: 33803130 DOI: 10.3390/ijms22052750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
460 Peres A, Dorneles GP, Boeira MCR, Schipper LL, Beretta Â, Vilela T, Andrade VM, Romão PRT. Acute fish oil supplementation modulates the inflammatory response after strenuous exercise in obese men: A cross-over study. Prostaglandins Leukot Essent Fatty Acids 2018;137:5-11. [PMID: 30293597 DOI: 10.1016/j.plefa.2018.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
461 Marchioli R, Levantesi G. n-3 PUFAs and heart failure. International Journal of Cardiology 2013;170:S28-32. [DOI: 10.1016/j.ijcard.2013.06.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
462 Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008;22:3595-606. [PMID: 18559988 DOI: 10.1096/fj.08-112201] [Cited by in Crossref: 296] [Cited by in F6Publishing: 276] [Article Influence: 21.1] [Reference Citation Analysis]
463 Brogliato AR, Moor AN, Kesl SL, Guilherme RF, Georgii JL, Peters-Golden M, Canetti C, Gould LJ, Benjamim CF. Critical role of 5-lipoxygenase and heme oxygenase-1 in wound healing. J Invest Dermatol 2014;134:1436-45. [PMID: 24226420 DOI: 10.1038/jid.2013.493] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
464 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
465 Balta MG, Loos BG, Nicu EA. Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1. Front Immunol 2017;8:1682. [PMID: 29312286 DOI: 10.3389/fimmu.2017.01682] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
466 Al-Shaer AE, Buddenbaum N, Shaikh SR. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158936. [PMID: 33794384 DOI: 10.1016/j.bbalip.2021.158936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10:427-439. [PMID: 20498669 DOI: 10.1038/nri2779] [Cited by in Crossref: 612] [Cited by in F6Publishing: 602] [Article Influence: 51.0] [Reference Citation Analysis]
468 Stables MJ, Shah S, Camon EB, Lovering RC, Newson J, Bystrom J, Farrow S, Gilroy DW. Transcriptomic analyses of murine resolution-phase macrophages. Blood. 2011;118:e192-e208. [PMID: 22012065 DOI: 10.1182/blood-2011-04-345330] [Cited by in Crossref: 182] [Cited by in F6Publishing: 176] [Article Influence: 16.5] [Reference Citation Analysis]
469 Doyle R, Godson C, Brennan E. Promoting resolution in kidney disease: are we nearly there yet? Curr Opin Nephrol Hypertens 2020;29:119-27. [PMID: 31599748 DOI: 10.1097/MNH.0000000000000558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J 2011;25:1441-8. [PMID: 21532053 DOI: 10.1096/fj.11-0502ufm] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 11.5] [Reference Citation Analysis]
471 Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007;179:7021-7029. [PMID: 17982093 DOI: 10.4049/jimmunol.179.10.7021] [Cited by in Crossref: 282] [Cited by in F6Publishing: 264] [Article Influence: 18.8] [Reference Citation Analysis]
472 Nelson JW, Leigh NJ, Mellas RE, McCall AD, Aguirre A, Baker OJ. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol 2014;306:C178-85. [PMID: 24259417 DOI: 10.1152/ajpcell.00284.2013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
473 Lau BY, Cohen DJ, Ward WE, Ma DW. Investigating the role of polyunsaturated fatty acids in bone development using animal models. Molecules 2013;18:14203-27. [PMID: 24248147 DOI: 10.3390/molecules181114203] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
474 Berger EA. Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis. Adv Exp Med Biol 2019;1161:3-12. [PMID: 31562617 DOI: 10.1007/978-3-030-21735-8_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
475 Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47:147-155. [PMID: 18198131 DOI: 10.1016/j.plipres.2007.12.004] [Cited by in Crossref: 693] [Cited by in F6Publishing: 606] [Article Influence: 46.2] [Reference Citation Analysis]
476 Das UN. Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus? Lipids Health Dis 2011;10:19. [PMID: 21261967 DOI: 10.1186/1476-511X-10-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
477 Hall TC, Bilku DK, Al-Leswas D, Neal CP, Horst C, Cooke J, Metcalfe MS, Dennison AR. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: a pilot study. JPEN J Parenter Enteral Nutr 2015;39:301-12. [PMID: 24408035 DOI: 10.1177/0148607113518945] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
478 Kim TH, Kim GD, Jin YH, Park YS, Park CS. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Int Immunopharmacol 2012;14:384-91. [PMID: 22951188 DOI: 10.1016/j.intimp.2012.08.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
479 Yamaguchi J, Kinoshita K, Ihara S, Furukawa M, Sakurai A. The Clinical Significance of Low Serum Arachidonic Acid in Sepsis Patients with Hypoalbuminemia. Intern Med 2018;57:1833-40. [PMID: 29491308 DOI: 10.2169/internalmedicine.9124-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
480 Yoo S, Lim JY, Hwang SW. Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives. Curr Neuropharmacol 2013;11:664-76. [PMID: 24396341 DOI: 10.2174/1570159X11311060009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
481 Oh SF, Vickery TW, Serhan CN. Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators. Biochim Biophys Acta 2011;1811:737-47. [PMID: 21712098 DOI: 10.1016/j.bbalip.2011.06.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
482 Zhang Y, Zhu Z, Li H, Zhu M, Peng X, Xin A, Qu R, He W, Fu J, Sun X. Resolvin E1 in Follicular Fluid Acts as a Potential Biomarker and Improves Oocyte Developmental Competence by Optimizing Cumulus Cells. Front Endocrinol (Lausanne) 2020;11:210. [PMID: 32373069 DOI: 10.3389/fendo.2020.00210] [Reference Citation Analysis]
483 Shinohara M, Serhan CN. Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation. J Atheroscler Thromb 2016;23:655-64. [PMID: 27052783 DOI: 10.5551/jat.33928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
484 Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2008;79:101-8. [DOI: 10.1016/j.plefa.2008.09.016] [Cited by in Crossref: 295] [Cited by in F6Publishing: 275] [Article Influence: 21.1] [Reference Citation Analysis]
485 Bäck M, Hansson GK. Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation. FASEB J 2019;33:1536-9. [PMID: 30703872 DOI: 10.1096/fj.201802445R] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 10.7] [Reference Citation Analysis]
486 Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr. 2012;142:592S-599S. [PMID: 22279140 DOI: 10.3945/jn.111.155259] [Cited by in Crossref: 483] [Cited by in F6Publishing: 421] [Article Influence: 48.3] [Reference Citation Analysis]
487 Tungen JE, Aursnes M, Dalli J, Arnardottir H, Serhan CN, Hansen TV. Total synthesis of the anti-inflammatory and pro-resolving lipid mediator MaR1n-3 DPA utilizing an sp(3) -sp(3) Negishi cross-coupling reaction. Chemistry 2014;20:14575-8. [PMID: 25225129 DOI: 10.1002/chem.201404721] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
488 Kieran NE, Maderna P, Godson C. Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney International 2004;65:1145-54. [DOI: 10.1111/j.1523-1755.2004.00487.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
489 Collodel G, Castellini C, Lee JC, Signorini C. Relevance of Fatty Acids to Sperm Maturation and Quality. Oxid Med Cell Longev 2020;2020:7038124. [PMID: 32089776 DOI: 10.1155/2020/7038124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
490 Akagi D, Chen M, Toy R, Chatterjee A, Conte MS. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. FASEB J 2015;29:2504-13. [PMID: 25777995 DOI: 10.1096/fj.14-265363] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
491 Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018;186:98-113. [PMID: 29352860 DOI: 10.1016/j.pharmthera.2018.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
492 Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M. Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes. Diabetes Metab Syndr Obes 2019;12:109-20. [PMID: 30662277 DOI: 10.2147/DMSO.S187268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
493 Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells. PLoS One 2014;9:e113480. [PMID: 25409514 DOI: 10.1371/journal.pone.0113480] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
494 Kasuga K, Suga T, Mano N. Bioanalytical insights into mediator lipidomics. J Pharm Biomed Anal 2015;113:151-62. [PMID: 25769667 DOI: 10.1016/j.jpba.2015.02.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
495 Sawada Y, Honda T, Nakamizo S, Otsuka A, Ogawa N, Kobayashi Y, Nakamura M, Kabashima K. Resolvin E1 attenuates murine psoriatic dermatitis. Sci Rep 2018;8:11873. [PMID: 30089836 DOI: 10.1038/s41598-018-30373-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
496 Tian H, Lu Y, Shah SP, Wang Q, Hong S. 14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury. Stem Cells Dev 2012;21:1187-99. [PMID: 21846180 DOI: 10.1089/scd.2011.0220] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
497 Calder PC. n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 2013;72:326-36. [DOI: 10.1017/s0029665113001031] [Cited by in Crossref: 219] [Cited by in F6Publishing: 90] [Article Influence: 24.3] [Reference Citation Analysis]
498 Wei Y, Liu Z, Zhu X, Jiang L, Shi W, Wang Y, Xu N, Gang F, Wang X, Zhao L, Lin J, Sun X. Dual directions to address the problem of aseptic loosening via electrospun PLGA @ aspirin nanofiber coatings on titanium. Biomaterials 2020;257:120237. [PMID: 32738656 DOI: 10.1016/j.biomaterials.2020.120237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
499 Ferbebouh M, Vallières F, Benderdour M, Fernandes J. The pathophysiology of immunoporosis: innovative therapeutic targets. Inflamm Res 2021;70:859-75. [PMID: 34272579 DOI: 10.1007/s00011-021-01484-9] [Reference Citation Analysis]
500 Rey C, Delpech JC, Madore C, Nadjar A, Greenhalgh AD, Amadieu C, Aubert A, Pallet V, Vaysse C, Layé S, Joffre C. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain. Brain Behav Immun 2019;76:17-27. [PMID: 30086401 DOI: 10.1016/j.bbi.2018.07.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
501 Das UN. Lipoxin A4 may function as an endogenous anti-arrhythmic molecule. Med Hypotheses 2011;76:14-6. [PMID: 20833483 DOI: 10.1016/j.mehy.2010.08.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
502 Ogata H, Teixeira MM, Sousa RC, Silva MV, Correia D, Rodrigues Junior V, Levy BD, Rogério Ade P. Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease. Eur J Pharmacol 2016;777:26-32. [PMID: 26927755 DOI: 10.1016/j.ejphar.2016.02.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
503 Schmöcker C, Gottschall H, Rund KM, Kutzner L, Nolte F, Ostermann AI, Hartmann D, Schebb NH, Weylandt KH. Oxylipin patterns in human colon adenomas. Prostaglandins Leukot Essent Fatty Acids 2021;167:102269. [PMID: 33812217 DOI: 10.1016/j.plefa.2021.102269] [Reference Citation Analysis]
504 Vella L, Markworth JF, Farnfield MM, Maddipati KR, Russell AP, Cameron-Smith D. Intramuscular inflammatory and resolving lipid profile responses to an acute bout of resistance exercise in men. Physiol Rep 2019;7:e14108. [PMID: 31257737 DOI: 10.14814/phy2.14108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
505 Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 2010;184:836-43. [PMID: 20007539 DOI: 10.4049/jimmunol.0901809] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 10.8] [Reference Citation Analysis]
506 Reinertsen AF, Primdahl KG, De Matteis R, Dalli J, Hansen TV. Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2n-3 DPA. Chemistry 2021;:e202103857. [PMID: 34890076 DOI: 10.1002/chem.202103857] [Reference Citation Analysis]
507 Flesher RP, Herbert C, Kumar RK. Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma. Clin Sci (Lond) 2014;126:805-14. [PMID: 24344649 DOI: 10.1042/CS20130623] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
508 Brooks JD, Milne GL, Yin H, Sanchez SC, Porter NA, Morrow JD. Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 2008;283:12043-55. [PMID: 18263929 DOI: 10.1074/jbc.M800122200] [Cited by in Crossref: 61] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
509 Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN. Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol 2008;180:3512-9. [PMID: 18292578 DOI: 10.4049/jimmunol.180.5.3512] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
510 Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 2008;112:848-855. [PMID: 18480426 DOI: 10.1182/blood-2007-11-122598] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 10.9] [Reference Citation Analysis]
511 Stables MJ, Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res. 2011;50:35-51. [PMID: 20655950 DOI: 10.1016/j.plipres.2010.07.005] [Cited by in Crossref: 211] [Cited by in F6Publishing: 199] [Article Influence: 17.6] [Reference Citation Analysis]
512 Crean D, Godson C. Specialised lipid mediators and their targets. Seminars in Immunology 2015;27:169-76. [DOI: 10.1016/j.smim.2015.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
513 Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007;30:980-92. [PMID: 17978156 DOI: 10.1183/09031936.00005807] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
514 Wolfer AM, Gaudin M, Taylor-Robinson SD, Holmes E, Nicholson JK. Development and Validation of a High-Throughput Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Approach for Screening of Oxylipins and Their Precursors. Anal Chem 2015;87:11721-31. [PMID: 26501362 DOI: 10.1021/acs.analchem.5b02794] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
515 Chiurchiù V, Leuti A, Dalli J, Jacobsson A, Battistini L, Maccarrone M, Serhan CN. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med 2016;8:353ra111. [PMID: 27559094 DOI: 10.1126/scitranslmed.aaf7483] [Cited by in Crossref: 159] [Cited by in F6Publishing: 158] [Article Influence: 31.8] [Reference Citation Analysis]
516 Dias IHK, Milic I, Heiss C, Ademowo OS, Polidori MC, Devitt A, Griffiths HR. Inflammation, Lipid (Per)oxidation, and Redox Regulation. Antioxid Redox Signal 2020;33:166-90. [PMID: 31989835 DOI: 10.1089/ars.2020.8022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
517 Hirahashi J, Kawahata K, Arita M, Iwamoto R, Hishikawa K, Honda M, Hamasaki Y, Tanaka M, Okubo K, Kurosawa M, Takase O, Nakakuki M, Saiga K, Suzuki K, Kawachi S, Tojo A, Seki G, Marumo T, Hayashi M, Fujita T. Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis. Sci Rep 2014;4:6406. [PMID: 25230773 DOI: 10.1038/srep06406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
518 Das UN. Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013;42:122-34. [DOI: 10.1016/j.pnpbp.2012.06.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
519 D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol. 2013;20:319-327. [PMID: 23283640 DOI: 10.1128/cvi.00636-12] [Cited by in Crossref: 164] [Cited by in F6Publishing: 97] [Article Influence: 18.2] [Reference Citation Analysis]
520 Preshaw PM. Host modulation therapy with anti-inflammatory agents. Periodontol 2000 2018;76:131-49. [DOI: 10.1111/prd.12148] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
521 Fraga VG, Carvalho MDG, Caramelli P, de Sousa LP, Gomes KB. Resolution of inflammation, n-3 fatty acid supplementation and Alzheimer disease: A narrative review. J Neuroimmunol 2017;310:111-9. [PMID: 28778434 DOI: 10.1016/j.jneuroim.2017.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
522 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
523 da-Palma-Cruz M, da Silva RF, Monteiro D, Rehim HMMA, Grabulosa CC, de Oliveira APL, Lino-dos-santos-franco A. Photobiomodulation modulates the resolution of inflammation during acute lung injury induced by sepsis. Lasers Med Sci 2019;34:191-9. [DOI: 10.1007/s10103-018-2688-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
524 Serini S, Ottes Vasconcelos R, Fasano E, Calviello G. How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer? Nutr Res Rev 2016;29:102-25. [PMID: 27172872 DOI: 10.1017/S0954422416000044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
525 Martin JM, Stapleton RD. Omega-3 fatty acids in critical illness. Nutr Rev. 2010;68:531-541. [PMID: 20796218 DOI: 10.1111/j.1753-4887.2010.00313.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
526 Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 2020;64:443-62. [PMID: 32885825 DOI: 10.1042/EBC20200018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
527 Abumrad NA, Piomelli D, Yurko-Mauro K, Merrill A, Clandinin MT, Serhan CN. Moving beyond "good fat, bad fat": the complex roles of dietary lipids in cellular function and health: session abstracts. Adv Nutr 2012;3:60-8. [PMID: 22332103 DOI: 10.3945/an.111.000802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
528 Aguilar-mogas A, Sales-pardo M, Navarro M, Guimerà R, Yanes O. iMet: A Network-Based Computational Tool To Assist in the Annotation of Metabolites from Tandem Mass Spectra. Anal Chem 2017;89:3474-82. [DOI: 10.1021/acs.analchem.6b04512] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
529 Mancini AD, Di Battista JA. The cardinal role of the phospholipase A2/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E2 (PCPP) axis in inflammostasis. Inflamm Res 2011;60:1083-92. [DOI: 10.1007/s00011-011-0385-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
530 Lu Y, Hong S, Tjonahen E, Serhan CN. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J Lipid Res 2005;46:790-802. [PMID: 15722568 DOI: 10.1194/jlr.D400020-JLR200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
531 Welty FK, Schulte F, Alfaddagh A, Elajami TK, Bistrian BR, Hardt M. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B4. FASEB J 2021;35:e21448. [PMID: 33749913 DOI: 10.1096/fj.202002471R] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
532 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
533 Tyurina YY, St Croix CM, Watkins SC, Watson AM, Epperly MW, Anthonymuthu TS, Kisin ER, Vlasova II, Krysko O, Krysko DV, Kapralov AA, Dar HH, Tyurin VA, Amoscato AA, Popova EN, Bolevich SB, Timashev PS, Kellum JA, Wenzel SE, Mallampalli RK, Greenberger JS, Bayir H, Shvedova AA, Kagan VE. Redox (phospho)lipidomics of signaling in inflammation and programmed cell death. J Leukoc Biol 2019;106:57-81. [PMID: 31071242 DOI: 10.1002/JLB.3MIR0119-004RR] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
534 Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, Muscara MN, Serhan CN, Van Dyke TE, Gyurko R. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008;155:1214-23. [PMID: 18806821 DOI: 10.1038/bjp.2008.367] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
535 Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res 2019;7:9. [PMID: 30937213 DOI: 10.1038/s41413-019-0047-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
536 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
537 Chiang N, de la Rosa X, Libreros S, Serhan CN. Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol 2017;198:842-51. [PMID: 27994074 DOI: 10.4049/jimmunol.1601650] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 12.8] [Reference Citation Analysis]
538 Kalenyak K, Heilmann RM, van de Lest CHA, Brouwers JF, Burgener IA. Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment. PLoS One 2019;14:e0215435. [PMID: 30990833 DOI: 10.1371/journal.pone.0215435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
539 Mizraji G, Heyman O, Van Dyke TE, Wilensky A. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. Front Immunol 2018;9:785. [PMID: 29922275 DOI: 10.3389/fimmu.2018.00785] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
540 Nosaka K, Miyoshi T, Iwamoto M, Kajiya M, Okawa K, Tsukuda S, Yokohama F, Sogo M, Nishibe T, Matsuo N, Hirohata S, Ito H, Doi M. Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study. Int J Cardiol 2017;228:173-9. [PMID: 27865182 DOI: 10.1016/j.ijcard.2016.11.105] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
541 Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
542 Xu YN, Zhang Z, Ma P, Zhang SH. Adenovirus-delivered angiopoietin 1 accelerates the resolution of inflammation of acute endotoxic lung injury in mice. Anesth Analg 2011;112:1403-10. [PMID: 21543779 DOI: 10.1213/ANE.0b013e318213fbd3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
543 Konieczka P, Barszcz M, Kowalczyk P, Szlis M, Jankowski J. The potential of acetylsalicylic acid and vitamin E in modulating inflammatory cascades in chickens under lipopolysaccharide-induced inflammation. Vet Res 2019;50:65. [PMID: 31533824 DOI: 10.1186/s13567-019-0685-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
544 Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR, Cameron-Smith D. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol 2013;305:R1281-96. [PMID: 24089379 DOI: 10.1152/ajpregu.00128.2013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
545 Rey C, Nadjar A, Buaud B, Vaysse C, Aubert A, Pallet V, Layé S, Joffre C. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Brain Behav Immun 2016;55:249-59. [PMID: 26718448 DOI: 10.1016/j.bbi.2015.12.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 10.1] [Reference Citation Analysis]
546 Chen CT, Liu Z, Ouellet M, Calon F, Bazinet RP. Rapid β-oxidation of eicosapentaenoic acid in mouse brain: An in situ study. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009;80:157-63. [DOI: 10.1016/j.plefa.2009.01.005] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 8.2] [Reference Citation Analysis]
547 Stamp LK, James MJ, Cleland LG. Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 2005;35:77-94. [PMID: 16194694 DOI: 10.1016/j.semarthrit.2005.05.001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
548 Rinaldi SF, Hutchinson JL, Rossi AG, Norman JE. Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Review of Clinical Immunology 2014;7:675-96. [DOI: 10.1586/eci.11.58] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
549 Vik A, Dalli J, Hansen TV. Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. Bioorg Med Chem Lett 2017;27:2259-66. [PMID: 28408222 DOI: 10.1016/j.bmcl.2017.03.079] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
550 Shen JH, Ma Q, Shen SR, Xu GT, Das UN. Effect of α-linolenic acid on streptozotocin-induced diabetic retinopathy indices in vivo. Arch Med Res 2013;44:514-20. [PMID: 24120388 DOI: 10.1016/j.arcmed.2013.09.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
551 Musso G, Cassader M, Paschetta E, Gambino R. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis. Gastroenterology. 2018;155:282-302.e8. [PMID: 29906416 DOI: 10.1053/j.gastro.2018.06.031] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 24.0] [Reference Citation Analysis]
552 Rogers LK, Valentine CJ, Keim SA. DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 2013;70:13-9. [PMID: 23266567 DOI: 10.1016/j.phrs.2012.12.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
553 Isobe Y, Arita M. Identification of novel omega-3 fatty acid-derived bioactive metabolites based on a targeted lipidomics approach. J Clin Biochem Nutr 2014;55:79-84. [PMID: 25320453 DOI: 10.3164/jcbn.14-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
554 Mittal A, Ranganath V, Nichani A. Omega fatty acids and resolution of inflammation: A new twist in an old tale. J Indian Soc Periodontol 2010;14:3-7. [PMID: 20922071 DOI: 10.4103/0972-124X.65426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
555 Ménard C, Patenaude C, Gagné AM, Massicotte G. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. J Neurosci Res 2009;87:876-86. [PMID: 18951489 DOI: 10.1002/jnr.21916] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
556 Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol 2016;7:160. [PMID: 27199985 DOI: 10.3389/fimmu.2016.00160] [Cited by in Crossref: 214] [Cited by in F6Publishing: 213] [Article Influence: 35.7] [Reference Citation Analysis]
557 Felau SM, Sales LP, Solis MY, Hayashi AP, Roschel H, Sá-Pinto AL, Andrade DCO, Katayama KY, Irigoyen MC, Consolim-Colombo F, Bonfa E, Gualano B, Benatti FB. Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial. Front Immunol 2018;9:336. [PMID: 29552010 DOI: 10.3389/fimmu.2018.00336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
558 Avanoǧlu Güler A, Rossi FW, Bellando-Randone S, Prevete N, Tufan A, Manetti M, de Paulis A, Matucci-Cerinic M. The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis. Front Immunol 2020;11:1249. [PMID: 32636845 DOI: 10.3389/fimmu.2020.01249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
559 Caldas AR, Catita J, Machado R, Ribeiro A, Cerqueira F, Horta B, Medeiros R, Lúcio M, Lopes CM. Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases. Pharmaceutics 2021;13:1202. [PMID: 34452163 DOI: 10.3390/pharmaceutics13081202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases. Front Immunol 2019;10:2241. [PMID: 31611873 DOI: 10.3389/fimmu.2019.02241] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
561 Adeyemi WJ, Olayaki LA. Diclofenac - induced hepatotoxicity: Low dose of omega-3 fatty acids have more protective effects. Toxicol Rep 2018;5:90-5. [PMID: 29854580 DOI: 10.1016/j.toxrep.2017.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
562 Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012;120:e60-72. [PMID: 22904297 DOI: 10.1182/blood-2012-04-423525] [Cited by in Crossref: 314] [Cited by in F6Publishing: 307] [Article Influence: 31.4] [Reference Citation Analysis]
563 Rodríguez-Carrio J, Coras R, Alperi-López M, López P, Ulloa C, Ballina-García FJ, Armando AM, Quehenberger O, Guma M, Suárez A. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis. Arthritis Rheumatol 2021;73:401-13. [PMID: 33001576 DOI: 10.1002/art.41537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
564 López-vicario C, Rius B, Alcaraz-quiles J, García-alonso V, Lopategi A, Titos E, Clària J. Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. European Journal of Pharmacology 2016;785:133-43. [DOI: 10.1016/j.ejphar.2015.03.092] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
565 Quitadamo PA, Comegna L, Cristalli P. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19. Front Public Health 2020;8:589736. [PMID: 33738273 DOI: 10.3389/fpubh.2020.589736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
566 Cao L, Wang Y, Wang Y, Lv F, Liu L, Li Z. Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages. Exp Ther Med 2021;22:1222. [PMID: 34603519 DOI: 10.3892/etm.2021.10656] [Reference Citation Analysis]
567 Malachowa N, Kobayashi SD, Quinn MT, DeLeo FR. NET Confusion. Front Immunol 2016;7:259. [PMID: 27446089 DOI: 10.3389/fimmu.2016.00259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
568 Choi G, Hwang SW. Modulation of the Activities of Neuronal Ion Channels by Fatty Acid-Derived Pro-Resolvents. Front Physiol 2016;7:523. [PMID: 27877134 DOI: 10.3389/fphys.2016.00523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
569 Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR Jr. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. FASEB J 2016;30:4192-201. [PMID: 27619672 DOI: 10.1096/fj.201600144RR] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
570 Clària J, López-vicario C, Rius B, Titos E. Pro-resolving actions of SPM in adipose tissue biology. Molecular Aspects of Medicine 2017;58:83-92. [DOI: 10.1016/j.mam.2017.03.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
571 Qu X, Zhang X, Yao J, Song J, Nikolic-Paterson DJ, Li J. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol 2012;228:506-19. [PMID: 22610993 DOI: 10.1002/path.4050] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
572 Colombo JS, Moore AN, Hartgerink JD, D'Souza RN. Scaffolds to control inflammation and facilitate dental pulp regeneration. J Endod 2014;40:S6-12. [PMID: 24698696 DOI: 10.1016/j.joen.2014.01.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
573 Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005;102:7671-7676. [PMID: 15890784 DOI: 10.1073/pnas.0409271102] [Cited by in Crossref: 433] [Cited by in F6Publishing: 399] [Article Influence: 25.5] [Reference Citation Analysis]
574 Romano M, Cianci E, Simiele F, Recchiuti A. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. European Journal of Pharmacology 2015;760:49-63. [DOI: 10.1016/j.ejphar.2015.03.083] [Cited by in Crossref: 88] [Cited by in F6Publishing: 89] [Article Influence: 12.6] [Reference Citation Analysis]
575 Artiach G, Carracedo M, Plunde O, Wheelock CE, Thul S, Sjövall P, Franco-Cereceda A, Laguna-Fernandez A, Arnardottir H, Bäck M. Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis. Circulation 2020;142:776-89. [PMID: 32506925 DOI: 10.1161/CIRCULATIONAHA.119.041868] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
576 Thatcher TH, Woeller CF, McCarthy CE, Sime PJ. Quenching the fires: Pro-resolving mediators, air pollution, and smoking. Pharmacol Ther 2019;197:212-24. [PMID: 30759375 DOI: 10.1016/j.pharmthera.2019.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
577 Ponce J, Ulu A, Hanson C, Cameron-smith E, Bertoni J, Wuebker J, Fisher A, Siu K, Marmelat V, Adamec J, Bhatti D. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders. Front Aging Neurosci 2022;14:780811. [DOI: 10.3389/fnagi.2022.780811] [Reference Citation Analysis]
578 Wu B, Werlin EC, Chen M, Mottola G, Chatterjee A, Lance KD, Bernards DA, Sansbury BE, Spite M, Desai TA, Conte MS. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. J Vasc Surg 2018;68:188S-200S.e4. [PMID: 30064835 DOI: 10.1016/j.jvs.2018.05.206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
579 Das UN. A defect in the activities of Δ6 and Δ5 desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. World J Diabetes 2011; 2(11): 176-188 [PMID: 22087354 DOI: 10.4239/wjd.v2.i11.176] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
580 Zhang X, Qu X, Sun YB, Caruana G, Bertram JF, Nikolic-Paterson DJ, Li J. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. PLoS One. 2013;8:e67471. [PMID: 23840712 DOI: 10.1371/journal.pone.0067471] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
581 Chen Y, Qiu X, Yang J. Comparing the In Vitro Antitumor, Antioxidant and Anti-Inflammatory Activities between Two New Very Long Chain Polyunsaturated Fatty Acids, Docosadienoic Acid (DDA) and Docosatrienoic Acid (DTA), and Docosahexaenoic Acid (DHA). Nutr Cancer 2021;73:1697-707. [PMID: 32781843 DOI: 10.1080/01635581.2020.1804949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
582 Chataigner M, Martin M, Lucas C, Pallet V, Layé S, Mehaignerie A, Bouvret E, Dinel AL, Joffre C. Fish Hydrolysate Supplementation Containing n-3 Long Chain Polyunsaturated Fatty Acids and Peptides Prevents LPS-Induced Neuroinflammation. Nutrients 2021;13:824. [PMID: 33801489 DOI: 10.3390/nu13030824] [Reference Citation Analysis]
583 Ma Y, Lindsey ML, Halade GV. DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov 2012;7:711-21. [PMID: 22724444 DOI: 10.1517/17460441.2012.694862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
584 Hall TC, Bilku DK, Neal CP, Cooke J, Fisk HL, Calder PC, Dennison AR. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients. Prostaglandins Leukot Essent Fatty Acids 2016;112:1-11. [PMID: 27637335 DOI: 10.1016/j.plefa.2016.07.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
585 Tian H, Lu Y, Shah SP, Hong S. 14S,21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds. J Biol Chem 2011;286:4443-53. [PMID: 21112969 DOI: 10.1074/jbc.M110.100388] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
586 Das UN. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. J Adv Res 2018;11:43-55. [PMID: 30034875 DOI: 10.1016/j.jare.2018.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
587 Buchmann R, Hasilik A, Nunn ME, Van Dyke TE, Lange DE. PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex: PMN responses in chronic periodontitis. Journal of Clinical Periodontology 2002;29:563-72. [DOI: 10.1034/j.1600-051x.2002.290613.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
588 Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. 2009;158:960-971. [PMID: 19594757 DOI: 10.1111/j.1476-5381.2009.00290.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 167] [Article Influence: 13.5] [Reference Citation Analysis]
589 Rius B, Clària J. Principles, Mechanisms of Action, and Future Prospects of Anti-inflammatory Drugs. In: Lanas A, editor. NSAIDs and Aspirin. Cham: Springer International Publishing; 2016. pp. 17-34. [DOI: 10.1007/978-3-319-33889-7_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
590 Joffre C, Rey C, Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front Pharmacol 2019;10:1022. [PMID: 31607902 DOI: 10.3389/fphar.2019.01022] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
591 Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75:645-662. [PMID: 22765297 DOI: 10.1111/j.1365-2125.2012.04374.x] [Cited by in Crossref: 646] [Cited by in F6Publishing: 569] [Article Influence: 71.8] [Reference Citation Analysis]
592 Tian R, Zuo X, Jaoude J, Mao F, Colby J, Shureiqi I. ALOX15 as a suppressor of inflammation and cancer: Lost in the link. Prostaglandins Other Lipid Mediat 2017;132:77-83. [PMID: 28089732 DOI: 10.1016/j.prostaglandins.2017.01.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
593 Pontes-Arruda A. Using parenteral fish oil to modulate inflammatory response. JPEN J Parenter Enteral Nutr 2010;34:344-5. [PMID: 19884351 DOI: 10.1177/0148607109348063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
594 Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem. 2003;278:43807-43817. [PMID: 12923200 DOI: 10.1074/jbc.m305841200] [Cited by in Crossref: 558] [Cited by in F6Publishing: 233] [Article Influence: 29.4] [Reference Citation Analysis]
595 Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007;178:3912-7. [PMID: 17339491 DOI: 10.4049/jimmunol.178.6.3912] [Cited by in Crossref: 402] [Cited by in F6Publishing: 368] [Article Influence: 26.8] [Reference Citation Analysis]
596 Grenon SM, Owens CD, Nosova EV, Hughes-Fulford M, Alley HF, Chong K, Perez S, Yen PK, Boscardin J, Hellmann J, Spite M, Conte MS. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). J Am Heart Assoc 2015;4:e002034. [PMID: 26296857 DOI: 10.1161/JAHA.115.002034] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
597 Rezaei A, Neshat S, Heshmat-Ghahdarijani K. Alterations of Lipid Profile in COVID-19: A Narrative Review. Curr Probl Cardiol 2021;:100907. [PMID: 34272088 DOI: 10.1016/j.cpcardiol.2021.100907] [Reference Citation Analysis]
598 Koutsostathis S, Tsaganos T, Giamarellos-bourboulis EJ, Kotsaki A, Papalois A, Efstathopoulos N. Eicosapentanoic acid prolongs survival and attenuates inflammatory response in an experimental model of lethal trauma. Prostaglandins, Leukotrienes and Essential Fatty Acids 2010;83:69-74. [DOI: 10.1016/j.plefa.2010.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
599 Calviello G, Serini S, Piccioni E, Pessina G. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer 2009;61:287-301. [PMID: 19373602 DOI: 10.1080/01635580802582777] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
600 O'Meara SJ, Rodgers K, Godson C. Lipoxins: update and impact of endogenous pro-resolution lipid mediators. Rev Physiol Biochem Pharmacol 2008;160:47-70. [PMID: 18481030 DOI: 10.1007/112_2006_0606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
601 Klawitter J, Klawitter J, McFann K, Pennington AT, Abebe KZ, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Gitomer B, Christians U, Schrier RW. Bioactive lipid mediators in polycystic kidney disease. J Lipid Res 2014;55:1139-49. [PMID: 24343898 DOI: 10.1194/jlr.P042176] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
602 Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 2012;107 Suppl 2:S171-84. [PMID: 22591891 DOI: 10.1017/S0007114512001560] [Cited by in Crossref: 232] [Cited by in F6Publishing: 102] [Article Influence: 23.2] [Reference Citation Analysis]
603 Dessì M, Noce A, Bertucci P, Manca di Villahermosa S, Zenobi R, Castagnola V, Addessi E, Di Daniele N. Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated Fatty acids. ISRN Inflamm 2013;2013:191823. [PMID: 24049656 DOI: 10.1155/2013/191823] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
604 Ramon S, Woeller CF, Phipps RP. The influence of Cox-2 and bioactive lipids on hematological cancers. Curr Angiogenes 2013;2:135-42. [PMID: 24883266 DOI: 10.2174/2211552802999140131105947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
605 Cadavid AP. Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications. Front Immunol 2017;8:261. [PMID: 28360907 DOI: 10.3389/fimmu.2017.00261] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
606 Hur SJ, Kang SH, Jung HS, Kim SC, Jeon HS, Kim IH, Lee JD. Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res. 2012;32:801-816. [PMID: 23176791 DOI: 10.1016/j.nutres.2012.09.013] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 8.9] [Reference Citation Analysis]
607 Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun. 2015;83:792-801. [PMID: 25486994 DOI: 10.1128/iai.02444-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 6.9] [Reference Citation Analysis]
608 Capra V, Rovati GE, Mangano P, Buccellati C, Murphy RC, Sala A. Transcellular biosynthesis of eicosanoid lipid mediators. Biochim Biophys Acta 2015;1851:377-82. [PMID: 25218301 DOI: 10.1016/j.bbalip.2014.09.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
609 Adolph M, Heller AR, Koch T, Koletzko B, Kreymann KG, Krohn K, Pscheidl E, Senkal M; Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine. Lipid emulsions - Guidelines on Parenteral Nutrition, Chapter 6. Ger Med Sci 2009;7:Doc22. [PMID: 20049078 DOI: 10.3205/000081] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
610 López-Vicario C, Rius B, Alcaraz-Quiles J, González-Périz A, Martínez-Puchol AI, Casulleras M, Duran-Güell M, Ibarzabal A, Corcelles R, Laguna-Fernández A, Back M, Titos E, Clària J. Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals. Sci Rep 2017;7:15724. [PMID: 29146976 DOI: 10.1038/s41598-017-15951-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
611 Günay S, Taşova F, Yılmaz HE, Paköz ZB, Çekiç C. Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis. Gastroenterol Res Pract 2019;2019:6258327. [PMID: 30906319 DOI: 10.1155/2019/6258327] [Reference Citation Analysis]
612 El Kebir D, Filep JG. Targeting neutrophil apoptosis for enhancing the resolution of inflammation. Cells 2013;2:330-48. [PMID: 24709704 DOI: 10.3390/cells2020330] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
613 Serhan CN, Lu Y, Hong S, Yang R. Mediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins. Lipidomics and Bioactive Lipids: Mass‐Spectrometry–Based Lipid Analysis. Elsevier; 2007. pp. 275-317. [DOI: 10.1016/s0076-6879(07)32012-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
614 Panigrahy D, Gartung A, Yang J, Yang H, Gilligan MM, Sulciner ML, Bhasin SS, Bielenberg DR, Chang J, Schmidt BA, Piwowarski J, Fishbein A, Soler-Ferran D, Sparks MA, Staffa SJ, Sukhatme V, Hammock BD, Kieran MW, Huang S, Bhasin M, Serhan CN, Sukhatme VP. Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. J Clin Invest 2019;129:2964-79. [PMID: 31205032 DOI: 10.1172/JCI127282] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
615 Hersberger M. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clinical Chemistry and Laboratory Medicine 2010;48. [DOI: 10.1515/cclm.2010.212] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
616 Pineda-peña EA, Jiménez-andrade JM, Castañeda-hernández G, Chávez-piña AE. Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury. European Journal of Pharmacology 2012;697:139-43. [DOI: 10.1016/j.ejphar.2012.09.049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
617 Rodríguez MJ, Sabaj M, Tolosa G, Herrera Vielma F, Zúñiga MJ, González DR, Zúñiga-Hernández J. Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation. Cells 2021;10:3406. [PMID: 34943914 DOI: 10.3390/cells10123406] [Reference Citation Analysis]
618 Nadjar A, Leyrolle Q, Joffre C, Laye S. Bioactive lipids as new class of microglial modulators: When nutrition meets neuroimunology. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017;79:19-26. [DOI: 10.1016/j.pnpbp.2016.07.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
619 N. Serhan C, Krishnamoorthy S, Recchiuti A, Chiang N. . CTMC 2011;11:629-47. [DOI: 10.2174/1568026611109060629] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
620 Davis TA, Gao L, Yin H, Morrow JD, Porter NA. In Vivo and in Vitro Lipid Peroxidation of Arachidonate Esters:  The Effect of Fish Oil ω-3 Lipids on Product Distribution. J Am Chem Soc 2006;128:14897-904. [DOI: 10.1021/ja064399o] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
621 Darwesh AM, Sosnowski DK, Lee TY, Keshavarz-bahaghighat H, Seubert JM. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system. Chemico-Biological Interactions 2019;308:20-44. [DOI: 10.1016/j.cbi.2019.04.037] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
622 Aursnes M, Tungen JE, Vik A, Colas R, Cheng CY, Dalli J, Serhan CN, Hansen TV. Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. J Nat Prod 2014;77:910-6. [PMID: 24576195 DOI: 10.1021/np4009865] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
623 Berrueta L, Muskaj I, Olenich S, Butler T, Badger GJ, Colas RA, Spite M, Serhan CN, Langevin HM. Stretching Impacts Inflammation Resolution in Connective Tissue. J Cell Physiol 2016;231:1621-7. [PMID: 26588184 DOI: 10.1002/jcp.25263] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
624 Romano M, Patruno S, Pomilio A, Recchiuti A. Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem Cells Transl Med 2019;8:992-8. [PMID: 31187940 DOI: 10.1002/sctm.19-0078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
625 Semerano L, Julia C, Aitisha O, Boissier MC. Nutrition and chronic inflammatory rheumatic disease. Joint Bone Spine 2017;84:547-52. [PMID: 27914804 DOI: 10.1016/j.jbspin.2016.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
626 de Paiva CS, Schwartz CE, Gjörstrup P, Pflugfelder SC. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 2012;31:1299-303. [PMID: 22257864 DOI: 10.1097/ICO.0b013e31823f789e] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
627 Corazza BJM, Martinho FC, Khoury RD, Toia CC, Orozco EIF, Prado RF, Machado FP, Valera MC. Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis. Int Endod J 2021;54:61-73. [PMID: 32896000 DOI: 10.1111/iej.13403] [Reference Citation Analysis]
628 Souza PR, Norling LV. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis. Eur J Pharmacol 2016;785:165-73. [PMID: 26165764 DOI: 10.1016/j.ejphar.2015.05.072] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
629 Suburu J, Lim K, Calviello G, Chen YQ. RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 2014;106:dju023. [PMID: 24685923 DOI: 10.1093/jnci/dju023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
630 Saric J. Interactions between immunity and metabolism - contributions from the metabolic profiling of parasite-rodent models. Parasitology 2010;137:1451-66. [PMID: 20602847 DOI: 10.1017/S0031182010000697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
631 Kanso F, Khalil A, Noureddine H, El-Makhour Y. Therapeutic perspective of thiosemicarbazones derivatives in inflammatory pathologies: A summary of in vitro/in vivo studies. Int Immunopharmacol 2021;96:107778. [PMID: 34162145 DOI: 10.1016/j.intimp.2021.107778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
632 Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007;31:12-26. [DOI: 10.1016/j.pnpbp.2006.07.010] [Cited by in Crossref: 190] [Cited by in F6Publishing: 153] [Article Influence: 12.7] [Reference Citation Analysis]
633 Kita Y, Takahashi T, Uozumi N, Nallan L, Gelb MH, Shimizu T. Pathway-oriented profiling of lipid mediators in macrophages. Biochem Biophys Res Commun 2005;330:898-906. [PMID: 15809081 DOI: 10.1016/j.bbrc.2005.03.055] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
634 Kwon O, Seo Y, Park H. Pinosylvin exacerbates LPS-induced apoptosis via ALOX 15 upregulation in leukocytes. BMB Rep 2018;51:302-7. [PMID: 29555013 DOI: 10.5483/bmbrep.2018.51.6.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Darwesh AM, Bassiouni W, Sosnowski DK, Seubert JM. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol Ther 2021;219:107703. [PMID: 33031856 DOI: 10.1016/j.pharmthera.2020.107703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
636 Barksdale C, Kipper FC, Tripathy S, Subbian S, Serhan CN, Panigrahy D. COVID-19 and cancer: start the resolution! Cancer Metastasis Rev 2022. [PMID: 35190921 DOI: 10.1007/s10555-021-10017-z] [Reference Citation Analysis]
637 Hesselink JM, Chiosi F, Costagliola C. Resolvins and aliamides: lipid autacoids in ophthalmology - what promise do they hold? Drug Des Devel Ther 2016;10:3133-41. [PMID: 27729772 DOI: 10.2147/DDDT.S112389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
638 Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007;447:869-74. [PMID: 17568749 DOI: 10.1038/nature05877] [Cited by in Crossref: 799] [Cited by in F6Publishing: 753] [Article Influence: 53.3] [Reference Citation Analysis]
639 Anders HJ. Immune system modulation of kidney regeneration--mechanisms and implications. Nat Rev Nephrol 2014;10:347-58. [PMID: 24776845 DOI: 10.1038/nrneph.2014.68] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
640 Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016;167:257-280. [PMID: 26207884 DOI: 10.1016/j.trsl.2015.06.017] [Cited by in Crossref: 120] [Cited by in F6Publishing: 110] [Article Influence: 17.1] [Reference Citation Analysis]
641 Fredman G, Serhan CN. Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis: Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis. Endod Topics 2011;24:39-58. [DOI: 10.1111/etp.12010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
642 Nanthirudjanar T, Furumoto H, Hirata T, Sugawara T. Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form. Lipids Health Dis 2013;12:73. [PMID: 23680128 DOI: 10.1186/1476-511X-12-73] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
643 Skarke C, Alamuddin N, Lawson JA, Li X, Ferguson JF, Reilly MP, FitzGerald GA. Bioactive products formed in humans from fish oils. J Lipid Res 2015;56:1808-20. [PMID: 26180051 DOI: 10.1194/jlr.M060392] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
644 Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011;50:372-87. [PMID: 21762726 DOI: 10.1016/j.plipres.2011.06.003] [Cited by in Crossref: 233] [Cited by in F6Publishing: 198] [Article Influence: 21.2] [Reference Citation Analysis]
645 Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kutsumi H, Inokuchi H, Serhan CN, Blumberg RS, Azuma T. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 2010;16:87-95. [PMID: 19572372 DOI: 10.1002/ibd.21029] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
646 Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol 2013;13:59-66. [PMID: 23197111 DOI: 10.1038/nri3362] [Cited by in Crossref: 312] [Cited by in F6Publishing: 204] [Article Influence: 31.2] [Reference Citation Analysis]
647 Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 2014;114:1867-79. [PMID: 24902971 DOI: 10.1161/CIRCRESAHA.114.302699] [Cited by in Crossref: 286] [Cited by in F6Publishing: 160] [Article Influence: 35.8] [Reference Citation Analysis]
648 Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids. 2005;73:163-177. [PMID: 16125378 DOI: 10.1016/j.plefa.2005.05.003] [Cited by in Crossref: 172] [Cited by in F6Publishing: 160] [Article Influence: 10.8] [Reference Citation Analysis]
649 El Amrousy D, Elashry H, Salamah A, Maher S, Abd-elsalam SM, Hasan S. Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial. JIR 2022;Volume 15:2075-86. [DOI: 10.2147/jir.s349502] [Reference Citation Analysis]
650 Medeiros FJ, Mothé CG, Aguila MB, Mandarim-de-lacerda CA. Long-term intake of edible oils benefits blood pressure and myocardial structure in spontaneously hypertensive rat (SHR) and streptozotocin diabetic SHR. Prostaglandins & Other Lipid Mediators 2005;78:231-48. [DOI: 10.1016/j.prostaglandins.2005.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
651 Wang JC, Strichartz GR. Prevention of Chronic Post-Thoracotomy Pain in Rats By Intrathecal Resolvin D1 and D2: Effectiveness of Perioperative and Delayed Drug Delivery. J Pain 2017;18:535-45. [PMID: 28063958 DOI: 10.1016/j.jpain.2016.12.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
652 Oh SF, Dona M, Fredman G, Krishnamoorthy S, Irimia D, Serhan CN. Resolvin E2 formation and impact in inflammation resolution. J Immunol 2012;188:4527-34. [PMID: 22450811 DOI: 10.4049/jimmunol.1103652] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 11.4] [Reference Citation Analysis]
653 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
654 Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M, Romano M, Recchiuti A. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 2018;11:35-49. [PMID: 28422188 DOI: 10.1038/mi.2017.36] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
655 Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury. J Immunol 2005;174:5033-9. [DOI: 10.4049/jimmunol.174.8.5033] [Cited by in Crossref: 195] [Cited by in F6Publishing: 189] [Article Influence: 11.5] [Reference Citation Analysis]
656 Tungen JE, Aursnes M, Ramon S, Colas RA, Serhan CN, Olberg DE, Nuruddin S, Willoch F, Hansen TV. Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents. Org Biomol Chem 2018;16:6818-23. [PMID: 30204204 DOI: 10.1039/c8ob01232f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
657 She Y, Zheng Q, Xiao X, Wu X, Feng Y. An analysis on the suppression of NO and PGE2 by diphenylheptane A and its effect on glycerophospholipids of lipopolysaccharide-induced RAW264.7 cells with UPLC/ESI-QTOF-MS. Anal Bioanal Chem 2016;408:3185-201. [DOI: 10.1007/s00216-016-9383-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
658 Wan M, Godson C, Guiry PJ, Agerberth B, Haeggström JZ. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1. FASEB J 2011;25:1697-705. [PMID: 21307335 DOI: 10.1096/fj.10-175687] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
659 van Bilsen M, Planavila A. Fatty acids and cardiac disease: fuel carrying a message. Acta Physiol 2014;211:476-90. [DOI: 10.1111/apha.12308] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
660 Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z, Tschopp J, Zhou R. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38:1154-1163. [PMID: 23809162 DOI: 10.1016/j.immuni.2013.05.015] [Cited by in Crossref: 407] [Cited by in F6Publishing: 379] [Article Influence: 45.2] [Reference Citation Analysis]
661 Uddin M, Levy BD. Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 2011;50:75-88. [PMID: 20887750 DOI: 10.1016/j.plipres.2010.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
662 Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006;176:1848-59. [PMID: 16424216 DOI: 10.4049/jimmunol.176.3.1848] [Cited by in Crossref: 318] [Cited by in F6Publishing: 297] [Article Influence: 19.9] [Reference Citation Analysis]
663 Urbitsch F, Elbert BL, Llaveria J, Streatfeild PE, Anderson EA. A Modular, Enantioselective Synthesis of Resolvins D3, E1, and Hybrids. Org Lett 2020;22:1510-5. [PMID: 32031820 DOI: 10.1021/acs.orglett.0c00089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
664 Börgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol 2012;3:318. [PMID: 23087692 DOI: 10.3389/fimmu.2012.00318] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
665 Motwani MP, Colas RA, George MJ, Flint JD, Dalli J, Richard-Loendt A, De Maeyer RP, Serhan CN, Gilroy DW. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation. JCI Insight 2018;3:94463. [PMID: 29563331 DOI: 10.1172/jci.insight.94463] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
666 Recchiuti A, Isopi E, Romano M, Mattoscio D. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation. Int J Mol Sci 2020;21:E6637. [PMID: 32927853 DOI: 10.3390/ijms21186637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
667 Kaput J, Ordovas JM, Ferguson L, van Ommen B, Rodriguez RL, Allen L, Ames BN, Dawson K, German B, Krauss R, Malyj W, Archer MC, Barnes S, Bartholomew A, Birk R, van Bladeren P, Bradford KJ, Brown KH, Caetano R, Castle D, Chadwick R, Clarke S, Clément K, Cooney CA, Corella D, Manica da Cruz IB, Daniel H, Duster T, Ebbesson SO, Elliott R, Fairweather-Tait S, Felton J, Fenech M, Finley JW, Fogg-Johnson N, Gill-Garrison R, Gibney MJ, Gillies PJ, Gustafsson JA, Hartman JL 4th, He L, Hwang JK, Jais JP, Jang Y, Joost H, Junien C, Kanter M, Kibbe WA, Koletzko B, Korf BR, Kornman K, Krempin DW, Langin D, Lauren DR, Ho Lee J, Leveille GA, Lin SJ, Mathers J, Mayne M, McNabb W, Milner JA, Morgan P, Muller M, Nikolsky Y, van der Ouderaa F, Park T, Pensel N, Perez-Jimenez F, Poutanen K, Roberts M, Saris WH, Schuster G, Shelling AN, Simopoulos AP, Southon S, Tai ES, Towne B, Trayhurn P, Uauy R, Visek WJ, Warden C, Weiss R, Wiencke J, Winkler J, Wolff GL, Zhao-Wilson X, Zucker JD. The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 2005;94:623-32. [PMID: 16277761 DOI: 10.1079/bjn20051585] [Cited by in Crossref: 97] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
668 Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I. Clinical Lipidology 2013;8:437-63. [DOI: 10.2217/clp.13.31] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
669 Clària J, González-Périz A, López-Vicario C, Rius B, Titos E. New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. Front Immunol 2011;2:49. [PMID: 22566839 DOI: 10.3389/fimmu.2011.00049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
670 James MJ, Proudman SM, Cleland LG. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 2003;68:399-405. [PMID: 12798660 DOI: 10.1016/s0952-3278(03)00064-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
671 Das UN. Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease? Lipids Health Dis 2008;7:19. [PMID: 18489792 DOI: 10.1186/1476-511X-7-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
672 Felton JM, Lucas CD, Rossi AG, Dransfield I. Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation. Front Immunol 2014;5:302. [PMID: 25071763 DOI: 10.3389/fimmu.2014.00302] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
673 Yang T, Terrando N. The Evolving Role of Specialized Pro-resolving Mediators in Modulating Neuroinflammation in Perioperative Neurocognitive Disorders. Adv Exp Med Biol 2019;1161:27-35. [PMID: 31562619 DOI: 10.1007/978-3-030-21735-8_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
674 Doi M, Nosaka K, Miyoshi T, Iwamoto M, Kajiya M, Okawa K, Nakayama R, Takagi W, Takeda K, Hirohata S, Ito H. Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study. International Journal of Cardiology 2014;176:577-82. [DOI: 10.1016/j.ijcard.2014.08.055] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
675 Serhan CN. Controlling the Resolution of Acute Inflammation: A New Genus of Dual Anti-Inflammatory and Proresolving Mediators. Journal of Periodontology 2008;79:1520-6. [DOI: 10.1902/jop.2008.080231] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
676 Dong L, Li Y, Wu H. Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids. Chem Phys Lipids 2021;239:105103. [PMID: 34116047 DOI: 10.1016/j.chemphyslip.2021.105103] [Reference Citation Analysis]
677 Dobson EP, Barrow CJ, Kralovec JA, Adcock JL. Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase. J Lipid Res 2013;54:1439-47. [PMID: 23471029 DOI: 10.1194/jlr.M036186] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
678 Hansen TV, Dalli J, Serhan CN. The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions. Prostaglandins Other Lipid Mediat 2017;133:103-10. [PMID: 28602942 DOI: 10.1016/j.prostaglandins.2017.06.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
679 Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM. Short-term physical inactivity impairs vascular function. J Surg Res 2014;190:672-82. [PMID: 24630521 DOI: 10.1016/j.jss.2014.02.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
680 Wang RX, Colgan SP. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Mol Aspects Med 2017;58:93-101. [PMID: 28232096 DOI: 10.1016/j.mam.2017.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
681 Sawane K, Nagatake T, Hosomi K, Hirata SI, Adachi J, Abe Y, Isoyama J, Suzuki H, Matsunaga A, Fukumitsu S, Aida K, Tomonaga T, Arita M, Kunisawa J. Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice. Nutrients 2019;11:E2868. [PMID: 31766714 DOI: 10.3390/nu11122868] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
682 Lu Y, Hong S, Yang R, Uddin J, Gotlinger KH, Petasis NA, Serhan CN. Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms. Rapid Commun Mass Spectrom 2007;21:7-22. [PMID: 17131464 DOI: 10.1002/rcm.2798] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
683 Milne GL, Yin H, Morrow JD. Human biochemistry of the isoprostane pathway. J Biol Chem 2008;283:15533-7. [PMID: 18285331 DOI: 10.1074/jbc.R700047200] [Cited by in Crossref: 139] [Cited by in F6Publishing: 58] [Article Influence: 9.9] [Reference Citation Analysis]
684 Ramon S, Bancos S, Serhan CN, Phipps RP. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. Eur J Immunol 2014;44:357-69. [PMID: 24166736 DOI: 10.1002/eji.201343316] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
685 Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int 2013;2013:824563. [PMID: 23762859 DOI: 10.1155/2013/824563] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
686 Deyama S, Shimoda K, Ikeda H, Fukuda H, Shuto S, Minami M. Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice. J Pharmacol Sci 2018;138:86-8. [PMID: 30293959 DOI: 10.1016/j.jphs.2018.09.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
687 Apaya MK, Lin CY, Chiou CY, Yang CC, Ting CY, Shyur LF. Simvastatin and a Plant Galactolipid Protect Animals from Septic Shock by Regulating Oxylipin Mediator Dynamics through the MAPK-cPLA2 Signaling Pathway. Mol Med 2016;21:988-1001. [PMID: 26701313 DOI: 10.2119/molmed.2015.00082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
688 Chao Y, Gao S, Wang X, Li N, Zhao H, Wen X, Lou Z, Dong X. Untargeted lipidomics based on UPLC-QTOF-MS/MS and structural characterization reveals dramatic compositional changes in serum and renal lipids in mice with glyoxylate-induced nephrolithiasis. Journal of Chromatography B 2018;1095:258-66. [DOI: 10.1016/j.jchromb.2018.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
689 Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory Resolution: new opportunities for drug discovery. Nat Rev Drug Discov 2004;3:401-16. [DOI: 10.1038/nrd1383] [Cited by in Crossref: 553] [Cited by in F6Publishing: 508] [Article Influence: 30.7] [Reference Citation Analysis]
690 McWilliam SJ, Wright RD, Welsh GI, Tuffin J, Budge KL, Swan L, Wilm T, Martinas IR, Littlewood J, Oni L. The complex interplay between kidney injury and inflammation. Clin Kidney J 2021;14:780-8. [PMID: 33777361 DOI: